Skip to Content

'
Ritsuko U. Komaki, MD, FACR, FASTRO

Present Title & Affiliation

Primary Appointment

Adjunct Professor, School of Health Sciences, Houston, TX
Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Gloria Lupton Tennison Distinguished Professorship in Lung Cancer, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Program Director and Section Chief, Thoracic Radiation Oncology, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Director, Thoracic Center, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1969 Hiroshima University School of Medicine, Hiroshima, Japan, MD, Medicine
1965 Hiroshima University, Hiroshima, Japan, BS, Biology

Postgraduate Training

1979-1980 Fellow, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
1/1977-1/1978 Fellow, Radiation Oncology, The Medical College of Wisconsin, Milwaukee, WI
1/1974-1/1977 Residency, Radiation Oncology, The Medical College of Wisconsin, Milwaukee County General Hospital, Milwaukee, WI
1/1973-1/1974 Fellow, Hemotology Oncology, VA Hospital, Hematology/Oncology Department, Milwaukee, WI
1/1972-1/1973 Intern, General, St. Mary's Hospital, Milwaukee, WI
1/1971-1/1972 Extern, St. Mary's Hospital, Milwaukee, WI
1/1969-1/1970 Intern, Medicine, Radiation Effects Research Foundation, Atomic Bomb Casualty Commission, Hiroshima, Japan

Board Certifications

1/1977 American Board of Radiology (Therapeutic Radiology)

Honors and Awards

2012-present Distinguished Emeritus Member, National Council on Radiation Protection & Measurements
2011-2012 America's Top Doctors for Cancer, Castle Connolly Medical Ltd.
2010-present America's Top Doctors for Cancer, Castle Connolly Medical Ltd.
2010-2011 Gold Medal Award, Japanese Association of Radiation Oncology
2010 Certificate of Appreciation, Japan Radiological Society
2009-present America's Top Doctors, Castle Connolly
2009-present America's Top Doctors for Cancer, Castle Connolly Medical, LTD
2009-present America's Top Oncologists, SLD Industries, Inc
2009-2010 Gold Medal Award, Japan Radiological Society
2009 2009 ASCO Cancer Foundation Merit Award, ASCO
2009 Best Doctors in America, Castle Connolly Top Doctors Recognitions
2009 Gold Medal Award, Japan Lung Cancer Society (JLCS)
2009 Houston's Top Doctors, H Texas Magazine
2009 Podcast on CR Magazine, CR magazine
2008-present America's Top Doctors In Radiation Oncology, Castle Connolly Guide
2008 Juan del Reato Gold Medal, 32nd Annual J. del Regato Gold Medal Lecture
2007 President of American Radium Society (ARS)
2007 America’s Top Doctors, Nation’s Leading Medical Specialists, Castles Connolly Guide
2006 Award from The Society in Tribute to Marie Sklodowska-Curie in Warsaw, Poland

Selected Publications

Peer-Reviewed Original Research Articles

1. Gomez DR, Gladish GW, Wei X, Kotamarti KR, Allen PK, Cox JD, O'Reilly MS, Erasmus JJ, Fossella FV, Komaki R. Prognostic value of positron emission tomography/computed tomography findings in limited-stage small cell lung cancer before chemoradiation therapy. Am J Clin Oncol 37(1):77-80, 2/2014. PMID: 23111360.
2. Welsh J, Palmer M, Jaffer A, Zhongxing L, Swisher S, Hofstetter W, Allen P, Settle S, Gomez D, Likhacheva A, Cox J, Komaki R. Esophageal cancer dose escalation using a simultaneous integrated boost technique. Int J Rad Onc Biol 82(1):468-474, 11/2012.
3. Machtay M, Bea K, Movsas B, Paulus R, Gore E, Komaki R, Albain K, Sause W, Curran W. Higher biologically equivalent dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 82(1):425-434, 11/2012.
4. Jiang ZQ, Yang K, Komaki R, Wei X, Tucker SL, Zhunag Y, Martel MK, Vedam S, Balter P, Zhu G, Gomez D, Lu C, Mohan R, Cox JD Liao Z. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small-cell lung cancer: The MD Anderson Experience. Int J Radiat Oncol Biol Phys 83(1):332-339, 11/2012.
5. Liu H, Zhang X, Vinogradskiy YY, Swisher S, Komaki R, Chang JY. Predicting radiation pneumonitis after stereotactic ablative radiotherapy in patients previously treated with conventional thoracic radiotherapy. Int J Radiat Oncol Biol Phys 84(4):1017-1023, 11/2012. PMID: 22543216.
6. Gomez DR, Tucker SL, Martel MK, Mohan R, Balter PA, Lopez Guerra JL, Liu H, Komaki R, Cox JD, Liao Z. Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84(4):1010-1016, 11/2012. PMID: 2292097.
7. Kong FM, Ritter T, Quint D, Marsh L, Senan S, GAspar L, Komaki R, Hurkmans C, Timmerman R, Choy H, Bezjak A, Bradley J, Mosvas B, Okunieff P, Curran W. In reply to Zagar and Marks. Int J Radiat Oncol Biol Phys 84(2):305-306, 10/2012.
8. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW Jr, Horn L, Jahan Tm, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Dris MG, Krug LM, Lennes IT, Loo BW Jr, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC, Hughes M, Gregory KM,. Non-small cell lung cancer. J Natl Compr Canc Netw 10:1236-12371, 10/2012.
9. Guerra JL, Gomez D, Wei Q, Liu Z, Wang LE, Yuan X, Zhuang Y, Komaki R, Liao Z. Association between single nucleotide polymorphisms of the transforming growth factor b1 gene and the risk of severe radiation esophagitis in patients with lung cancer. Radiother Oncol, 9/2012.
10. Chang JY, Liu H, Balter P, Komaki R, Liao Z, Welsh J, Mehran RJ, Roth JA, Swisher SG. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapyfor stage I non-small cell lung cancer. Radiat Oncol 10:152, 9/2012. PMID: 22963661.
11. Lopez Guerra JL, Gomez D, Zhuang Y, Hong DS, Heymach JV, Swisher SG, Lin SH, Komaki R, Cox JD, Liao Z. Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis. Int J Radiat Oncol Biol Phys 84(1):e61-7, 9/2012. PMID: 22503522.
12. Lopez Guerra JL, Gomez D, Lin S, Levy L, Zhuang Y, Komaki R, Jean J, Vaporciyan A, Swisher S, Cox JD, Liao Z, Rice D. Risk factors for local and regional recurrence in patients with resected N0-N1 non-smal cell lung caner, with implications for patient selection for adjuvant radiation therapy. Ann Oncol. e-Pub 9/2012.
13. Amini A, Correa AM, Komaki R, Chang JY, Tsao AS, Roth JA, Swisher SG, Rice DC, Vaporciyan AA, Lin SH. The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy. Ann Thorac Surg 94(3):914-920, 9/2012.
14. Bhardwaj V, Zhan Y, Cortez MA, Ang KK, Molkentine D, Munshi A, Raju U, Komaki R, Heymach JV, Welsh J. C-met inhibitor MK-8003 radiosensitizes c-met-expressing non-small-cell lung cancer cells with radiation-induced c-met-expression. J Thorac Oncol 7(8):1211-1217, 8/2012. PMID: 22617250.
15. Lopez Guerra JL, Gomez D, Zhuang Y, Levy L, Eapen G, Liu H, Mohan R, Komaki R, Cox J, Liao Z. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 83(5):1573-1579, 8/2012.
16. Xiang ZL, Erasmus J, Komaki R, Cox JD, Chang JY. FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy. Radiat Oncol 7:144, 8/2012.
17. Lin SH, Myles B, Wang L, Thall PF, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z. Propensity score based comparison of long term outcomes with 3D conformal radiotherapy (3DCRT) versus intensity modulated radiation therapy (IMRT) in the treatment of esophageal cancer. Inter J Radiat Oncol Biol Phys. e-Pub 8/2012. PMID: 22867894.
18. Ajani J, Correa A, Hofstetter W, Rice D, Blum M,. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 10:2638-2642, 7/2012. PMID: 22831985.
19. Amini A, Xiao L, Allen PK, Susuki A, Hayashi Y, Liao Z, Hofstetter W, Crane C, Komaki R, Bhutani MS. Lee JH, Ajani JA, Welsh J. Celiac node failure patterns after defitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys 83(2):e231-e239, 6/2012.
20. Lopez Guerra JL, Gomez D, Zhuang Y, Levy LB, Eapen G, Liu H, Mohan R, Komaki R, Cox JD, Liao Z,. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 83:e537, 6/2012.
21. Welsh J, Settle S, Amini A, Xiao L, Suzuki A, Hayashi Y, Hofstetter W, Komaki R, Liao Z. Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer 118(10):2632-2640, 5/2012. PMID: 22565611.
22. Komaki R, Paulus R, Ettinger DS, Videtic G MM, Bradley JD, Glisson BS, Langer CJ, Sause WT,. Curran WJ Jr., Choy H. Phase II study of accelerated high-dose radiation therapy with current chemotherapyf or patients with limited small cell lung cancre: RTOG 0239. Int J Radiat Oncol Biol Phys 83(4):e531-536, 5/2012. PMID: 22560543.
23. Zhang X, Liu H, Balter P, Allen PK, Komaki R, Pan T, Chuang HH, Chang JY. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small cell lung cancer. Int J Radiat Onc Biol Phys 83(5):1558-1565, 5/2012.
24. Swisher SG, Winter KA, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. A phase II study of a paclitaxel based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: Initial reporting of RTOG 0246. Int J Radia Oncol Biol Phys 82(5):1967-1972, 4/2012.
25. Koay EJ, Lege D, Mohan R, Komaki R, Cox JD, Chang JY. Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84(5). e-Pub 4/2012.
26. Machtay M, Paulus R, Moughan J, Komaki R, Bradley J, Choy H, Albain K, Movsas B, Sause WT, Curran WJ. Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma: a RadiationTherapy Oncology Group analysis. J Thorac Oncol 7(4):716-722, 4/2012.
27. Chi A, Liao Z, Nguyen NP, Xu J, Welsh JS, Jang SY, Howe C, Komaki R. Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases. PloS One 7(4):e35809, 4/2012.
28. Shirvani SM, Komaki R, Heymach JV, Fossella FV, Chang JY. Positron emission tomography/computed tomography-guided intensity-modulated radiotherapyf or limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 82(1):e91, 4/2012.
29. Lopez Guerra JL, Gomez D, Zhuang Y, Hong DS, Heymach JV, Swisher SG, Lin SH, Komaki R, Cox JD, Liao Z. Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis. Int J Radiat Oncol Biol Phys. e-Pub 4/2012.
30. Amini A, Lin SH, Wei C, Allen P, Cox JD, Komaki R. Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoerable non-small cell lung cancer. Radiat Oncol 15(7):33, 3/2012.
31. Amini A, Yang J, Williamson RT, McBurney ML, Erasmus J Jr., Allen PK, Karhade M, Komaki R, Liao Z, Gomez D, Cox JD, Dong L, Welsh J. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. Int J Radiat Oncol Biol Phys 82(3):e391, 3/2012.
32. Gomez D, Komaki R. Postoperative radiation therapy for non-small cell lung cancer and thymic malignancies. Cancer 4(1):307-322, 3/2012.
33. Lin SH, Komaki R, Liao Z, Wei C, Myles B, Guo X, Palmer M, Mohan R, Swisher SG, Hofstetter WL, Ajani JA, Cox JD. Proton beam therapy and concurent chemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 83(3). e-Pub 3/2012.
34. Wang J, Lin SH, Dong L, Balter P, Mohan R, Komaki R, Cox JD, Starkschall G. Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer. Int J Radiat Oncol Biol Phys 83(2):e273-80, 3/2012. PMID: 22440040.
35. Takahashi O, Komaki R, Smith PD, Jurensmeier JM, Ryan A, Bekele BN, Wistuba II, Jacoby JJ, Korshunova MV, Biernacka A, Erez B, Hosho K, Herbst RS, O'Reilly MS. Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis. ClinCancer Res 18(6):1-14, 2/2012.
36. Gomez DR, Cox JD, Roth JA, Allen PK, Wei X, Mehran RJ, Kim JY, Swisher SG, Rice DC, Komaki R. A prospective phase II study of surgery followed by chemotherapy and radiation for superior sulcus tumors. Cancer 118(2):444-451, 1/2012.
37. Yin M, Liao Z, Liu Z, Wang LE, O'Reilly M, Gomez D, Li M, Komaki R, Wei Q. Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy. Cancer 118(2):528-535, 1/2012.
38. Lopez Guerra JL, Gladish G, Komaki R, Gomez D, Zhuang Y, Liao Z. Large decreases in standardized uptake values after fefinitive radiation are associated with better survival of patients with locally advanced non-small cell lung cancer. J Nucl Med 53(2):225-233, 1/2012.
39. Ettinger DS, Akerley W, Borghaei H, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Schenck MP, Pister KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC. Malignant pleural mesothelioma. J Natl Compr Canc Netw 1(10):26-41, 1/2012.
40. Kong FM, Ritter T, Quint DJ, Senan S, Gaspar LE, Komaki R, Hurkmans CW, Timmerman R, Bezjak A, Bradley JD, Movsas B, Marsh L, Okunieff P, Choy H, Curran W. Consideration of dose limits for organs at risk for thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 81(5):1142-1457, 12/2011.
41. Komaki R, Wei X, Allen PK, Liao Z, Milas L, Cox JD, O'Reilly MS, Chang JY, McAleer MF, Jeter M, Blumenschein GR, Kies MS. Phase I study of celecoxib with concurrent irinotecan, cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer. Front Thorac Oncol 2(52):1-7, 12/2011.
42. Welsh J, Thomas J, Shah D, Allen PK, Wei X, Mitchell K, Gao S, Balter P, Komaki R, Chang JY. Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 81(1):91-96, 9/1/2011. e-Pub 6/11/2010. PMID: 20542388.
43. Chang JY, Komaki R, Wen HY, De Gracia B, Bluett JB, McAleer MF, Swisher SG, Gillin M, Mohan R, Cox JD. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 80(5):1350-1357, 8/1/2011. e-Pub 1/20/2011. PMCID: PMC3117089.
44. Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed Tomography Findings Predicting Invasiveness of Thymoma. J Thorac Oncol 6(7):1274-1281, 7/2011. PMID: 21623235.
45. Sejpal S, Komaki R, Tsao A, Chang JY, Liao Z, Wei X, Allen PK, Lu C, Gillin M, Cox JD. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer 117(13):3004-13, 7/2011. e-Pub 1/2011. PMID: 21264827.
46. Gomez D, Komaki R, Yu J, Ikushima H, Bezjak A. Radiation therapy definitions and reporting guidelines for thymic malignancies. J Thorac Oncol 6(7 Suppl 3):S1743-S1748, 7/2011. PMID: 21847057.
47. Chi A, Komaki R, Liao Z, Nam N, Howe C,. Intensity-modulated radiotherapy after extrapleural pneumonectomy in combined-modality treatment of malignant pleural mesothelioma. J Thorac Oncol 6(6), 6/2011.
48. Blumenschein GR, Paulus R, Curran WJ, Robert F, Fossella F, Werner-Wasik M, Herbst RS, Doescher PO, Choy H, Komaki R. Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG:0324. J Clin Oncol 29(17):2312-2318, 6/2011. e-Pub 5/2011. PMCID: PMC3107747.
49. Welsh J, Amini A, Likhacheva A, Erasmus J J, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee H J, Bhutani MS, Ajani JA. Update: Modern Approaches to the Treatment of Localized Esophageal Cancer. Curr Oncol Rep 13(3):157-67, 6/2011. e-Pub 3/2011. PMID: 21365188.
50. Grosshans D, Boehling NS, Palmer M, Spicer C, Erice R, Cox JD, Komaki R, Chang JY. Improving cardiac dosimerty: Alternative beam arrangements for intensity modulated radiation therapy planning in patients with carcinoma of the distal esophagus. PRO 2:41-45, 4/2011.
51. Welsh J, Gomez D, Palmer M, Riley B, Mayankkumar A, Komaki R, Dong L, Zhu R, Likhacheva A, Zhongxing L, HofstetterW , Jaffer A, Likhacheva A, Cox JD. Intensity-modulated proton therapy further reduces normal-tissue exposure during definitive therapy for locally advanced distal esophageal tumors: A dosimetric study. Int J Radiat Oncol Biol Phys 81(5):1336-1342, 4/2011.
52. Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience. Cancer 117(5):925-930, 3/1/2011. e-Pub 10/19/2010. PMCID: PMC3080168.
53. Kachnic LA, Winter K, Wasserman T, Kelson D, Ginsberg R, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Willett CG, Minsky BD. A longitudinal quality of life analysis of RTOG 94-05 (INT 0123): A phase III trial of definitive chemoradiation for esophageal cancer. Gastrointest Cancer Res 4(2):45-52, 3/2011.
54. Yin M, Liao Z, Liu Z, Wang LE, Gomez D, Komaki R, Wei Q. Functional polymorphisms of base-excision repair genes XRCC1 and APEX1 predict risk of radiation-induced pneumonitis in patients with non-small cell lung cancer Treated with Definitive radiatio therapy. Int J Radiat Oncol Biol Phys 81(3):e67-73, 3/2011.
55. Chang JY, Komaki R, Lu C, Wen HY, Allen PK, Tsao A, Gillin M, Mohan R, Cox JD. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer 117(20):4707-4713, 3/2011. PMCID: PMC3174272.
56. Ikushima H, Balter P, Komaki R, Hunjun S, Bucci MK, Liao Z, McAleer MF, Yu ZH, Zhang Y, Chang JY, Dong L. Daily alignment results of in-room computed tomography-Guided stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 79(2):473-480, 2/1/2011. e-Pub 4/14/2010. PMID: 20399032.
57. Fukui H, Toyoshima K, Komaki R. Psychological and neuroendocrinological effects of odor of saffron (Crocus sativus). Phytomedicine 18(8-9):726-730, 1/2011. PMID: 21242071.
58. Komaki R, Wei X, Allen PK, O'Reilly M, Fossella FV, Liao Z, Heymach JV, Herbst RS, Chang JY, Cox JD. (S044) Factors to predict long-term 5-year overall survival (OS) among patients with limited small-cell ling cancer treated with radiation treatment (RT) and chemotherapy. Oncology 25(1):27-28, 2011.
59. Bourhis J, Blanchard P, Maillard E, Brizel DM, Movsas B, Buentzel J, Langendik JA, Komaki R, Leong SS, Levendag P, Pignon JP. Effect of amifostine on survival among patients treated with radiotherapy: A meta-analysis of individual patient data. J Clin Oncol 29(18):2590-2597, 2011, 2011.
60. Turner LM, Howard JA, Dehghanpour P, Barrett RD, Rebueno N, Palmer M, Vedam S, Klopp A, Komaki R, Welsh JW. Exploring the feasibility of dose escalation positron emission tomography-positive disease with intensity-modulated radiation therapy and the effects on normal tissue structures for thoracic malignancies. Med Dosim 36(4):383-388, 2011. e-Pub 12/2010. PMID: 21144734.
61. Chi A, Jang SY, Welsh JS, Nguyen NP, Ong E, Gobar L, Komaki R. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage Non-small-cell lung cancer or lung metastases. Int J Radiat Oncol Biol Phys 81(3):856-862, 2011. PMID: 21255942.
62. Wolfson A, Bae K, Komaki R, Meyers C, Movsas, Le Pechoux C, Werner-Wasik M, Videtic G, Garces Y, Choy H. Primary analysis of a phase II randomized trial radiation therapy oncology group (RTOG) 0212: Impact of different total dose and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited disease small cell lung cancer. Int J Radiat Oncol Biol Phys 81(1):77-84, 2011.
63. Guan X, Liao Z, Ma H, Qian J, Liu Z, Yuan X, Gomez D, Komaki R, Wang LE, Wei Q. TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy. BMC Cancer 14(11):447, 2011. e-Pub 10/14/2011. PMCID: PMC3220654.
64. Kelly P, Balter PA, Rebueno N, Sharp HJ, Liao Z, Komaki R, Chang JY. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys 78(5):1387-1393, 12/1/2010. e-Pub 4/8/2010. PMID: 20381271.
65. Turner LM, Howard JA, Dehghanpour P, Barrett RD, Rebueno N, Palmer M, Vedam S, Klopp A, Komaki R, Welsh JW. Exploring the feasibility of dose escalation positron emission tomography–positive disease with intensity-modulated radiation therapy and the effects on normal tissue structures for thoracic malignancies. Med Dos, 12/2010. e-Pub 12/2010.
66. Chi A, Komaki R. Treatment of brain metastasis from lung cancer. Cancer 2(4):2100-2137, 12/2010.
67. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Govindan R, Grannis FW Jr, Jahan T, Johnson DH, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Le QT, Lennes IT, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pisters KM, RecKamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC; National Comprehensive Cancer Network. Thymic malignancies. J Natl Compr Canc Netw 8:1302-1315, 11/2010.
68. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Ajani JA, Erasmus J, Komaki R, Lee JH, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Peters JH, Watson TJ, Swisher SG. A clinical nomogram predicting pathologic lymph-node involvement in esophageal cancer patients. Ann Surg 252(6):611-617, 10/2010.
69. Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined modality therapy of cT2N0M0 esophageal caner: the Universit of Texas MD Anderson Cancer Center experience. Cancer 117(5):925-930, 10/2010.
70. Kong FM, Ritter T, Quint DJ, Senan S, Gaspar LE, Komaki RU, Hurkmans CW, Timmerman R, Bezjak A, Bradley JD, Movsas B, Marsh L, Okunieff P, Choy H, Curran WJ. Consideration of dose limits for organs at risk of thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 81(5):1442-1457, 10/2010.
71. Machtay M, Bae K, Movsas B, Paulus R, Byhardt R, Komaki R, Albain K, Sause WT, Curran WJ. Higher biologically equivalent dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the Radiation Therapy Oncology Group. JCO 82(1):425-434, 10/2010.
72. Gomez D, Komaki R. Technical advances of radiation therapy for thymic malignancies. J Thorac Oncol 5(10 Suppl 4):S336-43, 10/2010. PMID: 20859129.
73. Ogo E, Komaki R, Abe T, Uchida M, Fujimoto K, Suzuki G, Tsuji C, Suefuji H, Etou H, Hattori C, Watanabe Y, Hayabuchi N. The clinical characteristics and non-steroidal treatment for radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy. Radiother Oncol 97(1):95-100, 10/2010. e-Pub 4/10/2010. PMID: 20385415.
74. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved Long-term Outcome with Chemoradiotherapy Strategies in Esophageal Cancer. Ann Thorac Surg 90(3):892-8; discussion 898-9, 9/2010. PMID: 20732514.
75. Hildebrandt M, Komaki R, Liao Z, Gu J, Chang J, Ye Y, Lu C, Stewart D, Minna J, Roth J, Lippman S, Cox J, Hong W, Spitz M, Wu X. Genetic variants in inflammation pathway genes are associated with the development of radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One 5(8):e12402, 8/2010.
76. Wang XS, Shi Q, Williams LA, Mao L, Cleeland CS, Komaki RR, Mobley GM, Liao Z. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun 24(6):968-974, 8/2010. e-Pub 3/29/2010. PMCID: PMC2897921.
77. Wolfson AH, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux C, Werner-Wasik M, Videtic GM, Garces YI, Choy H. Primary analysis of a phase II randomized trial radiation therapy oncology group (RTOG) 0212: Impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited disease small cell lung cancer. Int J Radiat Oncol Biol Phys 81(1):77-84, 8/2010. PMCID: PMC3024447.
78. Tucker SL, Jin H, Wei X, Wang S, Martel MK, Komaki R, Liu HH, Mohan R, Chen Y, Cox JD, Liao Z. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 77(3):691-8, 7/1/2010. e-Pub 10/14/2009. PMID: 19836159.
79. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Jahan T, Jahanzeb M, Johnson DH, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Le QT, Lennes IT, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Simon GR, Swanson SJ, Wood DE, Yang SC, NCCN Non-Small Cell Lung Cancer Panel Members. Non-small cell lung cancer. J Natl Compr Canc Netw 8(7):740-801, 7/2010. PMID: 20679538.
80. Lu C, Lee JJ, Komaki R, Herbst RS, Feng L, Evans WK, Choy H, Desjardins P, Esparaz BT, Truong MT, Saxman S, Kelaghan J, Bleyer A, Fisch MJ. Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: A randomized phase III trial. J Natl Cancer Inst 102(12):859-62, 6/16/2010. e-Pub 5/26/2010. PMCID: PMC2902826.
81. Zhang X, Li Y, Pan X, Xiaoqiang L, Mohan R, Komaki R, Cox JD, Chang JY. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: A virtual clinical study. Int J Radiat Oncol Biol Phys 77(2):357-66, 6/1/2010. e-Pub 8/5/2009. PMCID: PMC2868090.
82. Chi A, Tomé WA, Fowler J, Komaki R, Nguyen NP, Mehta MP, Welsh JS. Stereotactic body radiation therapy in non-small-cell lung cancer: Linking radiobiological modeling and clinical outcome. Am J Clin Oncol 34(4):432-441, 6/2010. e-Pub 6/2010. PMID: 20539207.
83. Siddiqui F, Bae K, Langer CJ, Coyne JC, Gamerman V, Komaki R, Choy H, Curran WJ, Watkins-Bruner D, Movsas B. The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials. J Thorac Oncol 5(5):631-9, 5/2010. PMID: 20432520.
84. Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 4/1/2010. PMID: 20143431.
85. Chang JY, Komaki R, Wen Hy, DeGracia B, Bluett JB, McAleer MF, Swisher SG, Gillin M, Mohan R, Cox JD. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage. medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 80(5):1350-1357, 2011, 4/2010.
86. McAleer MF, Moughan J, Byhardt RW, Cox JD, Sause WT, Komaki R. Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808. Int J Radiat Oncol Biol Phys 76(3):802-808, 3/1/2010. e-Pub 6/18/2009. PMID: 19540055.
87. Liao ZX, Komaki RR, Thames HD, Liu HH, Tucker SL, Mohan R, Martel MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys 76(3):775-81, 3/1/2010. e-Pub 6/8/2009. PMID: 19515503.
88. Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 94(1):1-11, 1/2010. e-Pub 1/13/2010. PMID: 20074823.
89. Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y, Lu C, Stewart DJ, Minna JD, Roth JA, Lippman SM, Cox JD, Hong WK, Spitz MR, Wu X. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One 5(8):e12402, 2010. e-Pub 8/25/2010. PMCID: PMC2928273.
90. Guan X, Yin M, Wei Q, Zhao H, Liu Z, Wang LE, Yuan X, O'Reilly MS, Komaki R, Liao Z. Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy. BMC Cancer 10:431, 2010. e-Pub 8/16/2010. PMCID: PMC2939547.
91. Ikushima H, Dong L, Erasmus J, Allen P, McAleer MF, Zhuang Y, Sasaki R, Komaki R. Predictive value of (18)F-Fluorodeoxyglucose uptake by positron emission tomography for non-small cell lung cancer patients treated with radical radiotherapy. J Radiat Res 51(4):465-71, 2010. e-Pub 5/28/2010. PMID: 20508373.
92. Movsas B, Moughan J, Sarna L, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Wasserman T, Bruner DW. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol 27(34):5816-22, 12/2009. e-Pub 10/2009. PMCID: PMC2793002.
93. Ito A, Miyoshi M, Ueki S, Fukada M, Komaki R, Watanabe T. "Green odor" inhalation by rats down-regulates stress-induced increases in Fos expression in stress-related forebrain regions. Neurosci Res 65(2):166-74, 10/2009. e-Pub 6/27/2009. PMID: 19563846.
94. Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 133(4):831-836, 10/2009. e-Pub 4/9/2009. PMID: 19660349.
95. Komaki R, Cox JD. Molecular and physical targeting: A platform for improving the therapeutic ratio in cancer treatment. J Jpn Soc Ther Radiol Oncol 22:66, 9/2009.
96. Vallieres E, Shepherd FA, Crowley J, Van Houtte P, Postmus PE, Carney D, Chansky K, Shaikh Z, Goldstraw P. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 4(9):1049-59, 9/2009.
97. Smith A, Gillin M, Bues M, Zhu XR, Suzuki K, Mohan R, Woo S, Lee A, Komaki R, Cox J, Hiramoto K, Akiyama H, Ishida T, Sasaki T, Matsuda K. The M. D. Anderson Proton Therapy System. Med Phys 36(9):1-16, 9/2009. PMID: 19810479.
98. Sun M, Behrens C, Feng L, Ozburn N, Tang X, Yin G, Komaki R, Varella-Garcia M, Hong WK, Aldape KD, Wistuba II. HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors. Clin Cancer Res 15(15):4829-37, 8/1/2009. e-Pub 7/21/2009. PMID: 19622585.
99. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418, 8/2009. e-Pub 5/28/2009. PMCID: PMC2731793.
100. McGovern SL, Liao Z, Bucci MK, McAleer MF, Jeter MD, Chang JY, O'Reilly MS, Cox JD, Allen PK, Komaki R. Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer? Cancer 115(14):3233-42, 7/15/2009. e-Pub 5/2009. PMID: 19472405.
101. Oh Y, Taylor S, Bekele BN, Debnam JM, Allen PK, Suki D, Sawaya R, Komaki R, Stewart DJ, Karp DD. Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases. Cancer 115(13):2930-2938, 7/1/2009. e-Pub 5/13/2009. PMID: 19441110.
102. Bolton WD, Rice DC, Correa AM, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer. Am Surg 75(7):598-603, 7/2009. PMID: 19655604.
103. Zhang Z, Chen Y, Chen Y, Jeter M, Hofstetter WL, Ajani J, Swisher SG, Chang JY, Allen PK, Cox JD, Komaki R, Liao ZX. Outcomes with esophageal cancer radiation therapy. J Thorac Oncol 4(7):880-8, 7/2009. e-Pub 5/2009. PMID: 19458557.
104. Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, Mao L, Wang XS, Martel M, Komaki R, Cox JD, Milas L, Wei Q. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 27(20):3370-8, 7/2009. e-Pub 4/2009. PMID: 19380441.
105. Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P. The international association for the study of lung cancer staging project: Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 4(7):792-801, 7/2009. PMID: 19458556.
106. Smith GL, Smith BD, Buchholz TA, Liao Z, Jeter M, Swisher SG, Hofstetter WL, Ajani JA, McAleer MF, Komaki R, Cox JD. Patterns of Care and Locoregional Treatment Outcomes in Older Esophageal Cancer Patients: The SEER-Medicare Cohort. Int J Radiat Oncol Biol Phys 74(2):482-9, 6/1/2009. e-Pub 3/14/2009. PMID: 19289262.
107. Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, Komaki R, Chen Y, Martel MK, Mohan R, Cox JD, Liao Z. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol 91(3):427-32, 6/2009. e-Pub 10/18/2008. PMID: 18937989.
108. Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: a multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-87, 6/2009. PMID: 19464452.
109. Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG, Ajani JA, Hofstetter WL, Rashid A. Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival. Cancer 115(7):1576-85, 4/1/2009. PMID: 19156915.
110. Péchoux CL, Dunant A, Senan S, Wolfson A, Quoix E, Finn CF, Ciuleanu T, Arriagada R, Jones R, Wanders R, Lerouge D, Laplanche, A. Standard-dose versus higher-dose prophylactic cranial. Lancet 10(5):467-74, 4/2009.
111. Javeri H, Xiao L, Rohren E, Komaki R, Hofstetter W, Lee JH, Maru D, Bhutani MS, Swisher SG, Wang X, Ajani JA. Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer 115(3):624-30, 2/1/2009. PMID: 19130466.
112. Rosenzweig KE, Movsas B, Bradley J, Gewanter RM, Gopal RS, Komaki RU, Kong FM, Lee HK, Feins RH, Langer CJ. ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. J Am Coll Radiol 6(2):85-95, 2/2009. PMID: 19179235.
113. Gayed IW, Liu HH, Wei X, Liao Z, Yusuf SW, Chang JY, Bassett R, Komaki R. Patterns of cardiac perfusion abnormalities after chemoradiotherapy in patients with lung cancer. J Thorac Oncol 4(2):179-84, 2/2009. PMID: 19179893.
114. Britton KR, Starkschall G, Liu H, Chang JY, Bilton S, Ezhil M, John-Baptiste S, Kantor M, Cox JD, Komaki R, Mohan R. Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 73(1):94-102, 1/1/2009. e-Pub 10/17/2008. PMID: 18929448.
115. Zinner RG, Komaki R, Cox JD, Glisson BS, Pisters KM, Herbst RS, Kies M, Liao Z, Hong WK, Fossella FV. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: A phase I trial in patients with stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 73(1):119-27, 1/1/2009. e-Pub 6/14/2008. PMID: 18556142.
116. Cen P, Correa AM, Lee JH, Le JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009. e-Pub 11/19/2008. PMID: 19021684.
117. Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiat Oncol 4(1):5, 2009. PMCID: PMC2651897.
118. McDonald JM, Pelloski CE, Ledoux A, Sun M, Raso G, Komaki R, Wistuba II, Bekele BN, Aldape K. Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lung. Clin Cancer Res 14(23):7832-7, 12/1/2008. PMCID: PMC2614348.
119. Sarna L, Swann S, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Byhardt R, Wasserman T, Movsas B. Clinically Meaningful Differences in Patient-Reported Outcomes With Amifostine in Combination With Chemoradiation for Locally Advanced Non-Small-Cell Lung Cancer: An Analysis of RTOG 9801. Int J Radiat Oncol Biol Phys 75(5):1378-84, 12/2008. PMID: 18501528.
120. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest 134(6):1349; author reply 1350, 12/2008. PMID: 19059972.
121. Zhang X, Zhao KL, Guerrero TM, McGuire SE, Yarmko B, Komaki R, Cox J, Hui Z, Li Y, Newhauser WD, Mohan R, Liao Z. Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophagel cancer. Int J Radiat Oncol Bilo Phys 72(1):278-87, 9/2008. PMID: 18722278.
122. Wang H, Garden AS, Zhang L, Wei X, Ahamad A, Kuban DA, Komaki R, O'Daniel J, Zhang Y, Mohan R, Dong L. Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method. Int J Radiat Oncol Biol Phys 72(1):210-9, 9/2008. PMID: 18722272.
123. Gayed IW, Chang J, Kim EE, Nunez R, Chaen B, Liu HH, Kobayashi K, Zhang Y, Liao Z, Gohar S, Jeter M, Henderson L, Erwin W, Komaki R. Lung perfusion imaging can risk stratify lung cancer patients for the development of pulmonary complications after chemoradiation. J Thorac Oncol 3(8):858-64, 8/2008. PMID: 18670303.
124. Maru DM, Khurana H, Rashid A, Correa MA, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 32(9):1404-11, 8/2008. PMID: 18670347.
125. Ajani JA, Winter K, Komaki R, Kelsen DP, Minsky BD Liao Z, Bradley J, Fromm M, Hornback D, Willett CF. Phase II Randomized Trail of Two Nonoperative Regimens of Induction Chemotherapy Followed by Chemoradiation in Patients with Localized Carcinoma of the Esophagus RTOG 0113. J Clin Oncol Epub ahead of print, 6/2008. PMID: 18574157.
126. Ogo E, Komaki R, Fujimoto K, Uchida M, Abe T, Nakamura K , Mitsumori M, Kenji Sekiguchi K , Kaneyasu Y, Hayabuchi N. Lung lesions beyond the radiation field after tangential breast radiation - Radiation induced bronchiolitis obliterans organizing pneumonia (BOOP) syndrome after breast conserving therap. International Journal of Radiation Oncology and Physics 71(1):123-31, 5/2008.
127. Tetzlaff ED, Correa A, Komaki R, Swisher SG, Maru D, Ross W, Ajani JA. The Significance of Thromboembolic Phenomena Occurring Before and During Chemoradiotherapy for Localized Carcinoma of the Esophagus and Gastroesophageal Junction. Dis Esophagus 21(7):575-81, 5/2008.
128. Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R, Cox J, Chang J. Effects of Interfractional Motion and Anatomic Changes on Proton Therapy Dose Distribution in Lung Cancer. Int. J. Radiation Oncology Biol. Phys 72(5):1385-1395, 3/2008.
129. Ettinger DS, Akerley W, Bepler G, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Figlin RA, Govindan R, Grannis FW Jr, Jahan T, Jahanzeb M, Kessinger A, Komaki R, Kris MG, Langer CJ, Le QT, Martins R, Otterson GA, Patel JD, Robert F, Sugarbaker DJ, Wood DE. Non-small cell lung cancer. J Natl Compr Canc Netw 6(3):228-69, 3/2008. PMID: 18377844.
130. Grosshans DR, Meyers CA, Allen PK, Davenport SD, Komaki R. Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation. Cancer 112:589-595, 2/2008.
131. Ogo E, Komaki R, Fujimoto K, Uchida M, Abe T, Nakamura K, Mitsumori M, Sekiguchi K, Kaneyasu Y, Hayabuchi N. A survey of radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy in Japan. International Journal of Radiation Oncology Biology and Physics 71:123-131, 2008.
132. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Ajani JA, Phan A, Swisher SG, Mohan R, Cox JD, Komaki R. Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. Journal of Thoracic Oncology 3(3):277-282, 2008.
133. Yaremko BP, Guerrero TM, McAleer MF, Bucci MK, Noyola-Martinez J, Nguyen LT, Balter PA, Guerra R, Komaki R, Liao Z. Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography. International Journal of Radiation Oncology Biology and Physics 70:145-153, 2008.
134. Chang JY, Dong L, Liu H, Starkschall G, Balter P, Mohan R, Liao Z, Cox JD, Komaki R. Image-guided radiation therapy for non-small cell lung cancer. Journal of Thoracic Oncology 3(2):177-186, 2008.
135. Bruzzi JF, Komaki R, Walsh GL, Truong MT, Gladish GW, Munden RF, Erasmus JJ. Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management. Radiographics 28:551-560, 2008.
136. Bruzzi JF, Komaki R, Walsh GL, Truong MT, Gladish GW, Munden RF, Erasmus JJ. Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response. Radiographics 28:561-572, 2008.
137. Kased N, Erasmus JJ, Komaki R, Cox JD. Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review. Journal of Thoracic Oncology 3:534-538, 2008.
138. Cox JD, Sejpal S, Komaki R, Chang JY, McAleer MF, Liao Z, Tsao A, Kim ES, Wei X, Allen PK. Proton therapy with concurrent chemotherapy can reduce toxicity and allow higher radiation doses in advanced non-small cell lung cancer. J Thorac Oncol 3(Suppl 4):S303-S304, 2008.
139. Wei X, Liu H, Komaki R. Risk Factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive. Int J Radiat Oncol Biol Phys 70(3):707-714, 2008.
140. Zhang X, Komaki R, Wang L, Fang B, Chang JY. Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clinical Cancer Research 14:2813-2823, 2008.
141. Ezhil M, Starkschall G, Mohan R, Cox J, Komaki R. Validation of a model-based segmentation approach to propagating normal anatomic regions of interest through the 10 phases of respiration. Int J Radiat Oncol Biol Phys 71:900-906, 2008.
142. Fukui H, Komaki R, Okui M, Toyoshima K, Kuda K. The effects of odor on cortisol and testosterone in healthy adults. Neuro Endocrinol Lett 28(4):433-7, 8/2007. PMID: 17693981.
143. Liu HH, Balter P, Tutt T, Choi B, Zhang J, Wang C, Chi M, Luo D, Pan T, Hunjan S, Starkschall G, Rosen I, Prado K, Liao Z, Chang J, Komaki R, Cox JD, Mohan R, Dong L. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 68:531-40, 6/2007.
144. Yaremko BP, Guerrero TM, Noyola-Martinez J, Guerra R, Lege DG, Nguyen LT, Balter PA, Cox JD, Komaki R. Reduction of Normal Lung Irradiation in Locally Advanced Non-small cell lung cancer patients using ventilation images for functional avoidance. Int J Radiat Oncol Bol Phys 68:562-71, 6/2007.
145. Mell LK, Malik R, Komaki R, Movsas B, Swann RS, Langer C, Antonadou D, Koukourakis M, Mundt AJ. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: A meta-analysis. Int J Radiat Oncol Biol Phys 68:111-8, 5/2007. PMID: 17289291.
146. Yom SS, Liao Z, Liu HH, Tucker SL, Hu CS, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R. Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 68:94-102, 5/2007.
147. Podoloff DA, Advani RH, Allred C, Benson AB 3rd, Brown E, Burstein HJ, Carlson RW, Coleman RE, Czuczman MS, Delbeke D, Edge SB, Ettinger DS, Grannis FW Jr, Hillner BE, Hoffman JM, Kiel K, Komaki R, Larson SM, Mankoff DA, Rosenzweig KE, Skibber JM, Yahalom J, Yu JM, Zelenetz AD. NCCN Task Force Report: Positron Emission Tomography (PET)/Computed Tomography (CT) Scanning in Cancer. J Natl Compr Canc Netw Suppl 1:S1-S22, 5/2007.
148. Kang Y, Zhang X, Chang JY, Wang H, Wei X, Liao Z, Komaki R, Cox JD, Balter PA, Liu H, Zhu XR, Mohan R, Dong L. 4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys 67:906-14, 3/2007. PMID: 17293240.
149. Itasaka S, Komaki R, Herbst RS, Shibuya K, Shintani T, Hunter NR, Onn A, Bucana CD, Milas L, Ang KK, O'Reilly M S. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys 67:870-8, 3/2007. PMID: 17293237.
150. Guerrero T, Castillo R, Noyola-Martinez J, Torres M, Zhou X, Guerra R, Cody D, Komaki R, Travis E. Reduction of pulmonary compliance found with high-resolution computed tomography in irradiated mice. Int J Radiat Oncol Biol Phys 67:879-87, 3/2007. PMID: 17293238.
151. Gao XS, Qiao X, Wu F, Cao L, Meng X, Dong Z, Wang X, Gao G, Wu TT, Komaki R, Chang JY. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys 67:389-96, 2/2007. PMID: 17236963.
152. Wu W, Onn A, Isobe T, Itasaka S, Langley RR, Shitani T, Shibuya K, Komaki R, Ryan AJ, Fidler IJ, Herbst RS, O'Reilly MS. Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade. Mol Cancer Ther 6:471-83, 2/2007. PMID: 17308046.
153. Britton KR, Starkschall G, Tucker SL, Pan T, Nelson C, Chang, JY, Cox JD, Mohan R, Komaki R. Assessment of gross tumor volume regression and motion changes during radiation therapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 68:1036-1046, 2007.
154. Yendamuri S, Komaki R, Blackmon S, Correa A, Wynn B, Allen P, Hofstetter W, Rice, Roth J, Swisher S, Vapociyan AA, Walsh GL Mehran RJ. Comparison of Limited Surgery and Three-Dimetional Conformal Radiation in High-Risk Patients with Stage I Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 2(11):1022-8, 2007.
155. Huang EH, Liao Z, Cox JD, Guerrero TM, Chang JY, Jeter M, Borghero Y, Wei X, Fossella F, Herbst RS, Blumenschein GR, Moran C, Allen PK, Komaki R. Comparison of Outcomes for Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer Treated with Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation Alone. International Journal of Radiation Oncology Biology and Physics 68:779-786, 2007.
156. Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJ. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer 109:125-34, 2007.
157. Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW. Dose-Dependent Pulmonary Toxicity After Postoperative Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma. Int J Radiat Oncol Biol Phys 69:350-357, 2007.
158. Zhao KL, Liao Z, Bucci MK, Komaki R, Cox JD, Yu ZH, Zhang L, Mohan R, Dong L. Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiotherapy and Oncology 84:283-289, 2007.
159. Rohatgi PR, Correa AM, Swisher SG, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Lee JH, Rice DC, Roth JA, Ajani JA. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 19:152-7, 2007. PMID: 16722991.
160. Klopp AH, Chang JY, Tucker SL, Sulman EP, Balter PA, Liu HH, Bucci MK, Macapinlac HA, Komaki R, Cox JD. Intrathoracic Patterns of Failure for Non-Small Cell Lung Cancer with Positron Emission Tomography/ Computed Tomgraphy-Difined Target Delineation. International Journal of Radiation Oncology Biology and Physics 69(5):1409-1416, 2007.
161. Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, Erwin WD, Liao Z, Chang JY, Jeter M, Yaremko BP, Borghero YO, Cox JD, Komaki R, Mohan R. Preserving Functional Lung Using Perfusion Imaging and Intensity-Modulated Radiation Therapy for Advanced-Stage Non-Small-Cell Lung Cancer. Intl J Rad Oncol Biol Phys 68(5):1349-58, 2007.
162. Hofstetter WL, Correa AM, Ajani JA, Phan A, Komaki R, Liao Z, Wu T-T, Blackmon S, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Proposed Modification of Nodal Status in AJCC esophageal cancer staging system. Annuals of Thoracic Surgery 84:365-375, 2007.
163. Rice DC, Smyth RW, Liao Z, Guerrero T, Chang, JY, McAleer MF, Jeter MD, Correa A, Vaporcian AA, Lio HH, Komaki R, Forsater KM, Stevens CW. Pulmonary Toxicity Following Postoperative Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma. International Journal of Radiation Oncology Biology and Physics 69:350-357, 2007.
164. Guerrero T, Johnson V, Hart J, Pan T, Khan M, Luo D, Liao Z, Ajani J, Stevens C, Komaki R. Radiation pneumonitis: Local dose versus [(18)F]-fluorodeoxyglucose uptake response in irradiated lung. Int J Radiat Oncol Biol Phys 68:1030-1035, 2007.
165. Liao Z, Cox JD, Komaki R,. Radiochemotherapy of Esophageal Cancer. J Thor Oncol 2:553-568, 2007.
166. Shibuya K, Komaki R, Shintani T, Itasaka S, Ryan A, Jurgensmeier JM ,Milas L, Ang KK, Herbst RS, O’Reilly MS. Targeted therapy against VEGFR and EGFR with ZD 6474 enhances the therapeutic efficacy of irradiation in orthotopic model of human non-small lung cancer. International Journal of Radiation Oncology Biology and Physics 69:1534-1543, 2007.
167. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, Mohan R, Cox JD, Komaki R. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66:1399-407, 12/2006.
168. Komaki R, Liao Z, Liu H, Tucker S, Rice D. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma: in regard to Allen et al. (Int J Radiat Oncol Biol Phys 2006;65:640-645). Int J Radiat Oncol Biol Phys 66:1595-6; author reply 1596, 12/2006. PMID: 17126220.
169. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu T, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher S. Pre-Operative Chemoradiation –Induced Ulceration in Patients with Esophageal Cancer: A Confounding Factor in Tumor Response Assessment in Integrated CT-PET Imaging. J Thor Oncol 1:478-486, 12/2006.
170. Tucker SL, Liu HH, Wang S, Wei X, Liao Z, Komaki R, Cox JD, Mohan R. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 66:754-61, 11/2006. PMID: 16965865.
171. Klopp AH, Eapen GA, Komaki RR. Endobronchial brachytherapy: an effective option for palliation of malignant bronchial obstruction. Clin Lung Cancer 8:203-7, 11/2006. PMID: 17239296.
172. Sims-Mourtada J, Izzo JG, Apisarnthanarax S, Wu TT, Malhotra U, Luthra R, Liao Z, Komaki R, van der Kogel A, Ajani J, Chao KS. Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res 12:6565-72, 11/2006. PMID: 17085672.
173. Gayed IW, Liu HH, Yusuf SW, Komaki R, Wei X, Wang X, Chang JY, Swafford J, Broemeling L, Liao Z. The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer. J Nucl Med 47:1756-62, 11/2006. PMID: 17079807.
174. Wang KL, Yang Q, Cleary KR, Swisher SG, Correa AM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation. Cancer 107:1467-74, 10/2006. PMID: 16955509.
175. Fang LC, Komaki R, Allen P, Guerrero T, Mohan R, Cox JD. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 66:108-16, 9/2006. PMID: 16904517.
176. Wang SL, Liao Z, Liu HH, Ajani J, Swisher S, Cos J, Komaki R. Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 12(34):5501-8, 9/2006. PMID: 17006988.
177. Wang S, Liao Z, Liu H, Chen Y, Ajani J, Swisher S, Cox JD, Komaki R. Intensity-modulated radiotherapy (IMRT) with concurrent chemotherapy is an innovative treatment modality for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 34:5501-8, 9/2006.
178. Wang XS, Fairclough DL, Liao Z, Komaki R, Chang JY, Mobley GM, Cleeland CS. Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol 24(27):4485-91, 9/2006. PMID: 16983118.
179. Wei X, Liu HH, Tucker SL, Liao Z, Hu C, Mohan R, Cox JD, Komaki R. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66:100-7, 9/2006. PMID: 16839700.
180. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 107:967-74, 9/2006. PMID: 16874819.
181. Lee JJ, Bekele BN, Zhou X, Cantor SB, Komaki R, Lee JS. Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer. J Clin Oncol 24:3597-603, 8/2006. PMID: 16877726.
182. Ettinger DS, Bepler G, Bueno R, Chang A, Chang JY, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Grannis FW, Jr, Jahan T, Jahanzeb M, Kessinger A, Komaki R, Kris MG, Langer CJ, Le QT, Martins R, Otterson GA, Robert F, Sugarbaker DJ, Wood DE. Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 4:548-82, 7/2006. PMID: 16813724.
183. Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65:1087-96, 7/2006. PMID: 16682145.
184. Chang JY, Moughan J, Johnstone DW, Komaki R, Goldberg M, Langer CJ, Beadle BM, Owen J, Movsas B. Surgical patterns of care in operable lung carcinoma treated with radiation. J Thorac Oncol 1(6):526-31, 7/2006. PMID: 17409912.
185. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SG. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographis-positron emission tomographic imaging. J Thorac Onocl 1(5):478-86, 6/2006. PMID: 17409902.
186. Hu C, Chang EL, Hassenbusch SJ, 3rd, Allen PK, Woo SY, Mahajan A, Komaki R, Liao Z. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis. Cancer 106(9):1998-2004, 5/2006. PMID: 16572401.
187. Chang JY, Zhang X, Komaki R, Cheung R, Fang B. Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal adenocarcinoma. Int J Radiat Oncol Biol Phys 64(5):1482-94, 4/2006. PMID: 16580499.
188. Wang S, Liao Z, Chen Y, Chang JY, Jeter M, Guerrero T, Ajani J, Phan A, Swisher S, Allen P, Cox JD, Komaki R. Esophageal Cancer Located at the Neck and Upper Thorax Treated with Concurrent Chemoradiation: A Single-Institution Experience. J Thor Oncol 1:252-259, 3/2006.
189. Wang SL, Liao Z, Vaporciyan AA, Tucker SL, Liu H, Wei X, Swisher S, Ajani JA, Cox JD, Komaki R. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64(3):692-9, 3/2006. PMID: 16242257.
190. Guerrero T, Castillo R, Sanders K, Price R, Komaki R, Cody D. Novel method to calculate pulmonary compliance images in rodents from computed tomography acquired at constant pressures. Phys Med Biol 51(5):1101-12, 3/2006. PMID: 16481680.
191. Liao Z, Liu H, Swisher SG, Wang L, Wu TT, Correa AM, Roth JA, Cox JD, Komaki R, Ajani JA, Wei Q. Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 64(3):700-8, 3/2006. PMID: 16242255.
192. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TT. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106(5):1017-25, 3/2006. PMID: 16456809.
193. Guerrero T, Sanders K, Castillo E, Zhang Y, Bidaut L, Pan T, Komaki R. Dynamic ventilation imaging from four-dimensional computed tomography. Phys Med Biol 51(4):777-91, 2/2006. PMID: 16467578.
194. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Bresalier RS, Roth JA, Ajani JA. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer 106(3):552-8, 2/2006. PMID: 16353210.
195. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131(1):65-72, 2006. PMID: 16399296.
196. Wang S, Bruzzi J, Rodriguez-Garza VP, Komaki RR. Lambert-eaton myasthenic syndrome in a patient with small-cell lung cancer. Clin Lung Cancer 7(4):282-4, 2006. PMID: 16512985.
197. Rohatgi P, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Roth JA, Ajani JA. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104:2365-72, 12/2005. PMID: 16245310.
198. Chandra A, Guerrero TM, Liu HH, Tucker SL, Liao Z, Wang X, Murshed H, Bonnen MD, Garg AK, Stevens CW, Chang JY, Jeter MD, Mohan R, Cox JD, Komaki R. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol 77(3):247-53, 12/2005. PMID: 16298001.
199. Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Jr, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg 130(6):1601-10, 12/2005. PMID: 16308005.
200. Machtay M, Hsu C, Komaki R, Sause WT, Swann RS, Langer CJ, Byhardt RW, Curran WJ. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys 63:667-71, 11/2005. PMID: 15927409.
201. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Lynch PM, Rice DC, Roth JA, Ajani JA. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104(7):1349-55, 10/2005. PMID: 16130133.
202. Hong D, Lunagomez S, Kim EE, Lee JH, Bresalier RS, Swisher SG, Wu TT, Morris J, Liao Z, Komaki R, Ajani JA. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer 104(8):1620-6, 10/2005. PMID: 16118804.
203. Komaki R. What should the optimal timing be for amifostine administration relative to radiation and chemotherapy? J Clin Oncol 23(28):7232-3; author reply 7233-5, 10/2005. PMID: 16192612.
204. Zhang X, Cheung RM, Komaki R, Fang B, Chang JY. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer. Clin Cancer Res 11(18):6657-68, 9/2005. PMID: 16166445.
205. Chang JY, Liu HH, Komaki R. Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer. Curr Oncol Rep 7(4):255-9, 7/2005. PMID: 15946583.
206. Guerrero T, Sanders K, Noyola-Martinez J, Castillo E, Zhang Y, Tapia R, Guerra R, Borghero Y, Komaki R. Quantification of regional ventilation from treatment planning CT. Int J Radiat Oncol Biol Phys 62(3):630-4, 7/2005. PMID: 15936537.
207. Komaki R, Swann RS, Ettinger DS, Glisson BS, Sandler AB, Movsas B, Suh J, Byhardt RW. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12. Int J Radiat Oncol Biol Phys 62(2):342-50, 6/2005. PMID: 15890573.
208. Wakelee HA, Stephenson P, Keller SM, Wagner H, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590. Lung Cancer 48(3):389-97, 6/2005. PMID: 15893008.
209. Liao Z, Komaki R, Milas L, Yuan C, Kies M, Chang JY, Jeter M, Guerrero T, Blumenschien G, Smith CM, Fossella F, Brown B, Cox JD. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Clin Cancer Res 11(9):3342-8, 5/2005. PMID: 15867233.
210. Agarwal B, Swisher SG, Ajani J, Kelly K, Komaki RR, Abu-Hamda E, Correa AM, Roth JA. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux. Ann Thorac Surg 79(5):1716-23, 5/2005. PMID: 15854962.
211. Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705. J Clin Oncol 23(15):3480-3487, 5/2005. PMID: 15908657.
212. Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki RR, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241(5):810-7; discussion 817-20, 5/2005. PMID: 15849517.
213. Chang JY, Komaki R, Sasaki R, Liao Z, Stevens CW, Lu C, Fossella FV, Allen PK, Cox JD, Spitz MR, Wu X. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy. Clin Cancer Res 11(8):2894-8, 4/2005. PMID: 15837739.
214. Komaki R, Chang JY, Wu X, Allen PK, Milas L, Liao Z, Fossella FV, Travis E, Spitz MR. Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. Seminars in Oncology 32(Suppl 3):S92-S98, 4/2005. PMID: 16015542.
215. Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? Lung Cancer 48(1):93-102, 4/2005. PMID: 15777975.
216. Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, Wu TT. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103(7):1347-55, 4/2005. PMID: 15719440.
217. Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol 23(10):2145-54, 4/2005. PMID: 15800308.
218. Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61(3):656-64, 3/2005. PMID: 15708243.
219. Chirieac LR, Swisher SG, Correa AM, Ajani JA, Komaki RR, Rashid A, Hamilton SR, Wu TT. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Clin Cancer Res 11(6):2229-36, 3/2005. PMID: 15788671.
220. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam JB, Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23(6):1136-43, 2/2005. PMID: 15718309.
221. Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB, Jr, Komaki R, Ajani JA, Roth JA. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg 79(2):391-7; discussionn 391-7, 2/2005. PMID: 15680801.
222. Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61(2):318-28, 2/2005. PMID: 15667949.
223. Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Jr, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 60(5):1484-93, 12/2004. PMID: 15590179.
224. Koch N, Liu HH, Starkschall G, Jacobson M, Forster K, Liao Z, Komaki R, Stevens CW. Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part I--correlating internal lung motion with skin fiducial motion. Int J Radiat Oncol Biol Phys 60(5):1459-72, 12/2004. PMID: 15590177.
225. Liu HH, Koch N, Starkschall G, Jacobson M, Forster K, Liao Z, Komaki R, Stevens CW. Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part II-margin reduction of internal target volume. Int J Radiat Oncol Biol Phys 60(5):1473-83, 12/2004. PMID: 15590178.
226. Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Jr, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101(8):1776-85, 10/2004. PMID: 15386332.
227. Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 60(2):427-36, 10/2004. PMID: 15380576.
228. Arriagada R, Komaki R, Cox JD. Radiation dose escalation in non-small cell carcinoma of the lung. Semin Radiat Oncol 14(4):287-91, 10/2004. PMID: 15558502.
229. Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78(4):1152-60; discussion 1152-60, 10/2004. PMID: 15464463.
230. Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam JB, Jr, Abu-Hamda E, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 99(7):1258-66, 7/2004. PMID: 15233663.
231. Keller SM, Vangel MG, Wagner H, Schiller JH, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg 128(1):130-7, 7/2004. PMID: 15224032.
232. Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44(3):369-79, 6/2004. PMID: 15140551.
233. Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB, Jr, Lynch PM, Wu TT, Smythe R, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer 100(11):2347-54, 6/2004. PMID: 15160337.
234. Andratschke NH, Dittmann KH, Mason KA, Fan Z, Liao Z, Komaki R, Ang KK, Milas L. Epidermal growth factor receptor as a target to improve treatment of lung cancer. Clin Lung Cancer 5(6):340-52, 5/2004. PMID: 15217533.
235. Komaki R, Lee JS, Milas L, Lee HK, Fossella FV, Herbst RS, Allen PK, Liao Z, Stevens CW, Lu C, Zinner RG, Papadimitrakopoulou VA, Kies MS, Blumenschein GR, Jr, Pisters KM, Glisson BS, Kurie J, Kaplan B, Garza VP, Mooring D, Tucker SL, Cox JD. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58(5):1369-77, 4/2004. PMID: 15050312.
236. Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58(4):1258-67, 3/2004. PMID: 15001271.
237. Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58(4):1268-79, 3/2004. PMID: 15001272.
238. Komaki R, Liao Z, Milas L. Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer. Semin Oncol 31(1 Suppl 1):47-53, 2/2004. PMID: 14981580.
239. Butler LE, Forster KM, Stevens CW, Bloch C, Liu HH, Tucker SL, Komaki R, Liao Z, Starkschall G. Dosimetric benefits of respiratory gating: a preliminary study. J Appl Clin Med Phys 5(1):16-24, 2004. PMID: 15753930.
240. Taylor NA, Liao ZX, Cox JD, Stevens C, Roth J, Walsh G, Chang JY, Guerrero T, Jeter M, Putnam J, Jr, Fossella FV, Allen P, Komaki R. Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection. Int J Radiat Oncol Biol Phys 58(1):204-12, 2004. PMID: 14697440.
241. Brooks C, Starkschall G, Famiglietti R, Cox J, Frank S, Komaki R, Liao Z, Stevens C, Forster K. Heterogeneous planning for homogeneous protocols. Med Dosim 29(2):80-4, 2004. PMID: 15191752.
242. Cox JD, Le Chevalier T, Arriagada R, Choy H, Curran WJ, Fukuoka M, Harper P, Komaki R, Le Pechoux C, Lievens Y, Rami-Porta R, Ready N, Sause W, Stuschke M, Thatcher N. Management of unresectable non-small cell carcinoma of the lung (NSCLC). Lung Cancer 42 Suppl 1:S15-6, 12/2003. PMID: 14708518.
243. Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB, Jr, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe WR, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 57(5):1317-22, 12/2003. PMID: 14630268.
244. Movsas B, Moughan J, Komaki R, Choy H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, Abrams R, Munden R, Starkschall G, Owen J. Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol 21(24):4553-9, 12/2003. PMID: 14597743.
245. Ahamad A, Stevens CW, Smythe WR, Liao Z, Vaporciyan AA, Rice D, Walsh G, Guerrero T, Chang J, Bell B, Komaki R, Forster KM. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 9(6):476-84, 11/2003. PMID: 14740977.
246. Keller SM, Vangel MG, Wagner H, Schiller J, Herskovic A, Komaki R, Gray R, Marks RS, Perry MC, Livingston RB, Johnson DH. Second primary tumors following adjuvant therapy of resected stages II and IIIa non-small cell lung cancer. Lung Cancer 42(1):79-86, 10/2003. PMID: 14512191.
247. Ajani JA, Faust J, Yao J, Komaki R, Stevens C, Swisher S, Putnam JB, Vaporciyan A, Smythe R, Walsh G, Rice D, Roth J. Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer. Oncology (Williston Park) 17(9 Suppl 8):20-2, 9/2003. PMID: 14569843.
248. Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 57(1):120-7, 9/2003. PMID: 12909224.
249. Liao Z, Milas L, Komaki R, Stevens C, Cox JD. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer. Am J Clin Oncol 26(4):S85-91, 8/2003. PMID: 12902863.
250. Komaki R. Combined treatment for limited small cell lung cancer. Semin Oncol 30(4 Suppl 9):56-70, 8/2003. PMID: 12908137.
251. Frank SJ, Forster KM, Stevens CW, Cox JD, Komaki R, Liao Z, Tucker S, Wang X, Steadham RE, Brooks C, Starkschall G. Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription. Int J Radiat Oncol Biol Phys 56(5):1308-18, 8/2003. PMID: 12873675.
252. Johnson FM, Kurie JM, Peeples BO, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS. Dose-dense therapy with a novel irinotecan regimen for small-cell lung cancer. Oncology (Williston Park) 17(7 Suppl 7):17-21, 7/2003. PMID: 12886869.
253. Johnson FM, Kurie JM, Peeples BO, Lee JJ, Feng L, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer. Clin Lung Cancer 5(1):40-5, 7/2003. PMID: 14596703.
254. Taylor NA, Liao ZX, Stevens C, Walsh G, Roth J, Putnam J, Jr, Fossella F, Allen P, Cox JD, Komaki R. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery. Int J Radiat Oncol Biol Phys 56(3):616-25, 7/2003. PMID: 12788166.
255. Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21(13):2529-36, 7/2003. PMID: 12829672.
256. Lu C, Komaki R, Lee JS, Shin DM, Palmer JL, Coldman BJ, Pisters KM, Kurie JM, Fossella FV, Glisson BS. A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer. Clin Cancer Res 9(6):2085-91, 6/2003. PMID: 12796372.
257. Gopal R, Starkschall G, Tucker SL, Cox JD, Liao Z, Hanus M, Kelly JF, Stevens CW, Komaki R. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 56(1):114-20, 5/2003. PMID: 12694829.
258. Liao Z, Komaki R, Mason KA, Milas L. Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer. Clin Cancer Research 4(6):356-65, 5/2003. PMID: 14599301.
259. Gopal R, Tucker SL, Komaki R, Liao Z, Forster KM, Stevens C, Kelly JF, Starkschall G. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56(1):106-13, 5/2003. PMID: 12694828.
260. Ahamad A, Stevens CW, Smythe WR, Vaporciyan AA, Komaki R, Kelly JF, Liao Z, Starkschall G, Forster KM. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55(3):768-75, 3/2003. PMID: 12573764.
261. Forster KM, Smythe WR, Starkschall G, Liao Z, Takanaka T, Kelly JF, Vaporciyan A, Ahamad A, Dong L, Salehpour M, Komaki R, Stevens CW. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys 55(3):606-16, 3/2003. PMID: 12573747.
262. Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB, Jr, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL, Yin M. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res 9(1):93-101, 2003. PMID: 12538456.
263. Kaplan B, Stevens CW, Allen P, Liao Z, Komaki R. Outcomes and patterns of failure in bronchial carcinoid tumors. Int J Radiat Oncol Biol Phys 55(1):125-31, 2003. PMID: 12504044.
264. Komaki R, Liao Z, Foster K, Lee H, Stevens C, Cox J. Target Definition and contouring in Carcinoma of the Lung and Esophagus. RAYS 28(3):225-236, 2003.

Invited Articles

1. Komaki R. National Comprehensive Cancer Network (NCCN): Non-Small Cell Lung Cancer Guidelines. Expert Panel Member CD ROM, 2007.
2. Komaki R. Comprehensive Cancer Network (NCCN): Non-Small Cell Lung Cancer Guidelines. Expert Panel Member CD ROM, 2006.
3. Yang Q, Cleary KR, Yao JC, Swisher SG, Roth JA, Lynch PM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen. Dis Esophagus 17(1):38-43, 2004. PMID: 15209739.
4. Komaki R, Liao Z, Forster K, Lee HK, Stevens CW, Cox JD. Target definition and contouring in carcinoma of the lung and esophagus. Rays 28(3):225-36, 7/2003. PMID: 15018311.
5. Sanders KE, Komaki R, Buchholz TA. Target delineation and treatment planning in breast conserving therapy. Rays 28(3):237-45, 7/2003. PMID: 15018312.
6. Cox JD, Schechter NR, Lee AK, Forster K, Stevens CW, Ang KK, Komaki R, Liao Z, Milas L. Uncertainties in physical and biological targeting with radiation therapy. Rays 28(3):211-5, 7/2003. PMID: 15018309.
7. Komaki R. Aggressive palliative radiotherapy for a patient with a malignant superior sulcus tumor and adrenal metastasis. A case report. . The Lung Quarterly Scan 4(4):3, 2003.

Abstracts

1. Liao Z, Tucker SL, Gomez DR, Grosshans DR, Zhuang Y, Krafft SP,Martel MK, Mohan R, Komaki R, Cox JD. Heart and lung radiation and overall survival in non-small cell lung cancer patients after chemoradiation therapy. Int J Radiat Oncol Biol Phys 84(3S):S578, 11/2012.
2. Welsh J, Likacheva A, Byers LA, Bhardwaj V, Diao L, Wang J, Ang A, Komaki R, Kim E, Heymach JV,. Implications of KRAS mutations on outcomes in non-small cell lung cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys 84(35):S70, 11/2012.
3. Fakhreddine M, Liao Z, Zhuang Y, Bhardwaj V, Tucker S, Skinner H, Heymach JB, Gomez, DR, Komaki R, Welsh J. Poor glycemic control during radiochemotheray contributes to reduced local control and overall survival in patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84(35):S69, 11/2012.
4. Wei X, Gomez D, Zhunag Y, Komaki R, O'Reilly MS, Mohan R. Pretreatment poor pulmonary function is prognostic of poor ove3rall survival in patients with stage III non-small cell lung cancer treated with external beam radiation therapy. Int J Radiat Oncol Biol Phys 84(3S):S570, 11/2012.
5. Juloori A, Shirvani SM, Allen P, Komaki R, Liao Z, Welsh J, Gomez D, Heymach JV, Chang JY,. Limited-stage small cell lung cancer in the contemporary period: Impact of new technologies on outcomes. J Thora Oncol 7(9):S329, 9/2012.
6. Komaki R, Allen PK, Wei X, Blumenschein GR, Wistuba II, Lee J, Welsh J, O'Reilly MS, Tang XM, Hong WK,. The phase II trial of erotinib and radiotheray folling chemoradiotherapy for patients with stage III non-small cell lung cancer has shown a favorable response profile. J Thorac Oncol 7(9):S279, 9/2012.
7. Komaki R, Allen P, Wei X, Gomez D, Fossella F, Heymach J, Welsh J, O'Reilly MO, Lin S, Cox JD. Thoracic radiotherapy within 6 weeks with concurrent chemotherapy improved outcome of patients with limited stage small cell lung cancer (LS-SCLC). J Thorc Oncol 7(9):S217, 9/2012.
8. Komaki R, Kim YB, Wistuva II, Tang X, Meyn R, Allen PK, Wei X, Lee JJ, O'Reilly MS, Hong WK,. Vimentin (EMT marker protein) score predicts resistance to erlotinib and radiotherapy for patients with stage III non-small cell lung cancer on a prospective phase II trial. J Thorac Oncol 7(9):S220, 9/2012.
9. McAvoy S, Gomez D, Allen PK, Rineer J, Liao Z, Chang JY, Welsh J, Palmer MB, Cox JD, Komaki R,. Efficacy and toxicity of re-irradiation with proton beam therapy for non-small cell lung cancer: An updated institutional experience. Oncology 26(1):7, 4/2012.
10. Komaki R, Blumenschein G, Wistuba I, Lee JJ, Allen P, Wei X, Welsh J, O'Reilly M, Tang XM, Hong WK. The phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small-cell lung cancer has shown a favorable response profile. Oncology 26(1):6, 4/2012.
11. Komaki R, Amini A, Roth JA, Swisher SG, Pisters K, Lin SH. Post operative radiotherapy (PORT) for patients with stage III non-small cell lung cancer with persistent N2 diseae after induction chemotherapy: Do we need more personalized PORT?. Jap J Lung Cancer 51(5):331, 10/2011.
12. Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 6(7):1274-1281, 2011.
13. Komaki R, Wisuba I, X Ming Tang, Meyn RE, JJ Lee, Wei X, Allen PK, O'Reilly M, Welsh J, Hong WK. Phase II study of chemoradiation therapy abd erlotinib for stage III non-small cell lung cancer. Proceedings of AACR 102nd Annual Meeting Innovaton and collaboration: The path to Progress 52:636, 2011.
14. Komaki R. Phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small cell lung cancer. J Clinic Oncol 29(15S):458s, 2011, 2011.
15. Komaki RU, Wei X, Allen PK, O'Reilly MS, Fossella FV, Liao ZX, Heymach JV, Herbst RS, Chang JY, Cox JD. Factors to predict long-term five years overall survival (OS) among patients with limited small cell lung cancer treated with radiation treatment (RT) and chemotherapy. J Thor Onc - Supplement 5(12):S549, 12/2010.
16. Mohan R, Zhang Z, Matney J, Bluett J, Dong L, Balter P, Engelsman M, Choi N, Komaki R, Liao Z. IMRT vs. Passively Scattered Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer Randomized Trial - Is there Equipoise?. Proceedings of ASTRO 52 Annual Meeting 78(3):S201, 11/2010.
17. Shirvani SM, Komaki R, Stewart DJ, Lippman SM, Chang JY. PET/CT guided involved field intensity modulated radiation therapy for limited-stage small cell lung cancer. Proceedings of ASTRO 52nd Meeting 78(3):S34, 11/2010.
18. Likhacheva A, Thomas J, Kim E, Allen PK, Komaki R, Cox J, Herbst R, Welsh J. Predictive implications of KRAS and EGFR gene mutations in non-small cell lung cancer treated with radiation therapy. Proceedings of ASTRO 52nd Meeting 78(3):S128, 11/2010.
19. Liao Z, Wei Q, Martel MK, Gomez D, Liu Z, Guan X, Zhuang Y, Lu C, Komaki R, Tucker SL. Incorporating SNPs as biomarkers to improve the fit of the lyman model for radiation pneumonitis. Proceedings of the 52nd Annual ASTRO Meeting 78(3):S199, 10/2010.
20. Welsh JW, Riley B, Palmer MB, Amin MV, Komaki R, Gomez D, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity modulated proton therapy allows dose escalation and normal-tissue sparing in locally advanced distal esophageal tumors. Proceedings of the 52nd Annual ASTRO Meeting 78(3):S808, 10/2010.
21. Zhang Z, Balter P, Allen PK, Chuang H, Pan T, Lin Q, Komaki R, Chang JY. PET/CT and outcome in lung cancer treated with stereotactic body radiation therapy. Proceedings of ASTRO 52nd Meeting 78(3):S16, 10/2010.
22. Gomez DR, Tucker SL, MArtel MK, Zhuang Y, Balter PA, Lopez JL, Jiang CZ, Komaki R, Cox JD, Liao Z. Predictive dosimetric factors for high grade esophagitis in patients treated for non-small cell lung cancer (NSLC) with definitive 3D conformal therapy (3D-CRT), intensity modulated radiation therapy (IMRT), or proton beam therapy (PBT). Proceedings of the 52nd Annual ASTRO Meeting 78(3):S202, 10/2010.
23. Komaki RU, Khalid N, Kong FS, Langer C, Crozier C, Owen J, Wilson J, Movsas B. Report of quality research in radiation oncology (QRRO) survey for lung cancer patients treated in the USA between 2006 and 2007. Proceedings of the 52nd Annual ASTRO Meeting 78(3):S36, 10/2010.
24. Komaki R. Clinical outcomes and treatment planning strategies for advanced stage non small cell lung cancer (NSCLC) treated by intensity modulated radiation therapy (IMRT) or 3 dimentional conformal radiation therapy (3DCRT) with concurrent chemotherapy (CCT). J Thor Onc 5(5):S29, 5/2010.
25. Komaki R, Allen P, Roth J, Swisher S, Rice D, Fossella F, Herbst R, Oh Y, Munden R, Cox J. Optimal treatment for superior sulcus tumors (SST): Surgery first followed by adjunct RT/ChT improved survival for patients with resectable SST. Suppl Journal of Japan Radiological Society:S65, 4/2010.
26. Komaki R. Pros and cons of intensity modulated radiation therapy (IMRT) with concurrent chemotherapy for patients with inoperable stage III non small cell lung cancer. Suppl Journal of Japan Radiological Society:S90, 4/2010.
27. Yuan X, Tucker S, Komaki R, Martel M, Zhuang Y, Cox J, Milas L, Mohan R, Liao Z. Association between treatment-related pneumonitis and the overall survival after definitive radiotherapy for non–small cell lung cancer. Proceedings of the 51st Annual ASTRO Meeting Yuan X, Tucker S, Komaki R, Martel M, Zhuang Y, Cox J, Milas L, Mohan R, Liao Z 75(3):S473, 11/2009.
28. Xiaomao G, Lia ZX, Komaki R, Wen H, Chang JY, O'Reilly M, Jeter M, Bucci K, Ajani J, Cox JD. Concurrent chemotherapy and proton beam therapy for esophageal cancer. Proceedings of the 51st ASTRO Annual Meeting 75(3):S289-90, 11/2009.
29. Grosshans DR, Bae K, Blumenschein G, Curran W, Robert F, Fossella F, Wasik M, Doescher P, Choy H, Komaki R. Correlation of pulmonary and cardiac dose–volume histogram (DVH) data with the development of radiation adverse events following chemoradiation: Secondary analysis of radiation therapy oncology group (RTOG) 0324. Proceedings of the 51 Annual ASTRO Meeting 75(3):S161-62, 11/2009.
30. Vedam S, Tucker S, Zhuang Y, Mohan R, Komaki R, Liao Z, Martel M. Does the choice of a 4D CT reference dataset for treatment planning affect normal tissue dose response model parameters for non small cell lung cancer patients?. Proceedings of the 51st Annual ASTRO Meeting 75(3):S611, 11/2009.
31. Joyy S, Kong F, Komaki R, Gaspar L, Bonner JA, Sun A, Sandler H, Choy H, Movsas B. Factors associated with patterns of practice for elective nodal irradiation in non-small cell lung cancer patients among US radiation oncologists. Proceedings of the 51st Annual ASTRO Meeting 75(3):S129-30, 11/2009.
32. Chang JY, Komaki R, Bucci MK, Lu C, Wen HY, DeGarcia B, Gillin M, Mohan R, Cox JD. Failure patterns and toxicity of concurrent proton therapy and chemotherapy for stage III non–small cell lung cancer. Proceedings of the 51st Annual ASTRO Meeting 75(3):S446-7, 11/2009.
33. Gao S, Chang JY, Welsh J, Komaki R, Balter P. Influence of the couch and immobilization device used during stereotactic body radiotherapy on skin dose. Proceedings of the 51st Annual ASTRO Meeting 75(3):S682, 11/2009.
34. Palmer MB, Vedam S, Komaki R, Welsh JW. Intensity modulated radiation therapy (IMRT) benchmarks for thoracic malignancies. Proceedings of the 51st Annual ASTRO Meeting 75(3):S476, 11/2009.
35. Wei X, Allen PK, Laio Z, Chang JY Guerrero TM, Cox JD, Komaki R. Prophylactic cranial irradiation is more important to improve the overall survival among patients with limited small–cell lung cancer who received one-cycle induction chemotherapy and had complete response to therapy. Proceedings of the 51st Annual ASTRO Meeting 75(3):S462, 11/2009.
36. Wolfson A, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux C, Wasik M, Videtic G, Garces Y, Choy H. Secondary endpoints of a phase II randomized trail (RTOG 0212): Impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life patients with limited disease small-cell lung cancer. Proceedings of the 51st Annual ASTRO Meeting 75(3):S34, 11/2009.
37. Liao Z, Yuan X, Komaki R, Milas R, Liu Z, Wang L, Tucker SL, Mao L, Wang S, Martel M. Single nucleotide polymorphism of the TGF-B1 T869C gene associates risks of treatment related pneumonitis and distant metastasis in patients with non–small-cell lung cancer treated with definitive radiotherapy. Proceedings of ASTRO 51st Annual Meeting 75(3):S437, 11/2009.
38. Welsh J, Thomas J, Wei X, Allen P, Mitchell K, Gao S, Komaki R, Chang J. Skin toxicity and pain in patients treated with stereotactic body radiotherapy. Proceedings of the 51st Annual ASTRO Meeting 75(3):S61, 11/2009.
39. Kelly P, Balter PA, Rebueno N, Laio Z, Komaki R, Chang JY. Stereotactic body radiation therapy results in promising local control in patients with recurrent or secondary lung parenchyma cancer after definitive conventional thoracic radiotherapy. Proceedings of the 51st Annual ASTRO Meeting 75(3):S159, 11/2009.
40. Bruner D, Bae K, Siddiqui F, Langer CJ, Coyne J, Gamerman V, Komaki R, Choy H, Curran WJ, Movsas B. The influence of gender, race, and marital status on survival in lung cancer patients: Meta-analysis of radiation therapy oncology group (RTOG) trials. Proceedings of the 51st Annual ASTRO Meeting 75(3):S163, 11/2009.
41. Dawood O, Chang JY, Balter PA, Komaki R, Roth JA. Complexities of lung sterotactic radiotherapy planning target volumes. Supplement of J Thoac Oncol 4(9):S941-2, 9/2009.
42. Siddiqui F, Langer CJ, Bae K, Coyne J, Gamerman V, Bryan C, Komaki R, Choy H, Curran W, Watkins BD, Movsas B. Gender differences in survival amoung lung cancer patients treated in radiation therapy oncology group (RTOG) trails. Supplement of J Thorac Oncol 4(9):S524, 9/2009.
43. Yuan X, Liao Z, Komaki R, Liu Z, Tucker SL, Li M, Martel M, Cox JD, Milas L, Wei Q. Heterozygous CT genotype of TGFB1 at T869C was associated with a worse outcome in patients with non-small-cell lung cancer treated with definitive radiotherapy. Supplement of J Thorac Oncol 4(9):S912, 9/2009.
44. Komaki R, Liao Z, Chang JY, Sejpal SV, Wei X, Mohan R, Allen P, Tucker S, Cox JD. Intensity-modulated related radiation therapy (IMRT) in patients with locally advanced non-small-cell lung cancer treated with concurrent chemotherapy: good or bad. Supplement to J Thorac Oncol 4(9):S161, 9/2009.
45. Takahashi O, Komaki R, Smith PD, Ryan A, Jurgensmeier JM, Welsh JW, Jacoby JJ, Hosho K, Korshunova MV, Erez B, Herbst RS, OReilly MS. MEK1/2 blocakade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib. Supplement of J Thorac Oncol 4(9):S593, 9/2009.
46. Komaki R, Paulus R, Ettinger D, Videtic G, Bradley J, Glisson B, Choy H. Normal tissue toxicities in a phase II study of accelerated high dose thoracic radiation therapy (TRT) with concurrent chemotherapy for limited small cell lung cancer (LSCLC): radiation therapy oncology group (RTOG) 0239. Supplement of J Thorac Oncol 4(9):S392-3, 9/2009.
47. Chang JY, Komaki R, Wen H, Garcia B, Gillin M, Mohan R, Cox JD. Toxicity and patterns of failure of dose-escalated proton therapy in early-stage medically inoperable non-small cell lung cancer. Supplement of J Thoac Oncol 4(9):S525, 9/2009.
48. Komaki R, Paulus R, Ettinger DS, Videtic GM, Glisson J, Choy H,. A phase II study of accelerated high-dose thoracic radiation with concurrent chemotherapy for limited small cell lung cancer: RTOG 0239. Journal of Clinical Oncology - ASCO 27(15S):388s, 5/2009.
49. Komaki R, Liao Z, Jeter M, O'Reilly M, Wei X, Allen P, Chang JY, McAleer M, Cox JD, Kies M. A phase I study of concurrent CPT-11/cisplatin and celecoxib with radiation therapy for patients with unresectable non-small cell lung caner (NSCLC). Oncology - ARS 23(4):12, 4/2009.
50. Liao Z, Yuan X, Komaki R, Liu Z, Tucker SL, Mao L, Martel M, Cox JD, Milas L, Wei Q,. Association between heterogous CT genotype of TGF-Beta 1 gene at RS1982073:T869C and the outcomes of patients with non-small cell lung cancer treated with definitive radiotherapy. Oncology - ARS 23(4):11, 4/2009.
51. Komaki R, Sejpal S, Wei X, Allen P, Amos R, Mohan R, Chang J, Liao Z, Dong L, Cox JD. Proton Beam Therapy (PBT) Reduced Bone Marrow Toxicity (BMT) Compared to Intensity Modulated Radiation Therapy (IMRT) Among Patients with Locally Advanced (LA) NSCLC Treated with Concurrent Chemotherapy (CT). Journal of Japan Radiological Society 25:S89, 4/2009.
52. Wei X, Komaki R, Allen PK, Glisson BS, Stewart DJ, Liao Z, Fossella F, Jeter M, Chang JY, Guerrero T, Blumenschein G, Herbst R, Bucci BK, McAleer MF, Cox JD. Accelerated Hyperfractionated Radiation Therapy (AHF-RT) Increased Survival Compared to Daily Radiation Therapy (QD-RT) For Limited Small Cell Lung Cancer Patients Treated with Concurrent Chemotherapy. Supplement to Oncology 90(Supp 3):S60, 3/2009.
53. Wei X, Komaki R, Allen PK, Glisson BS, Stewart DJ, Liao Z, Fossella F, Jeter M, Chang JY, Guerrero T, Blumenschein G, Herbst R, Bucci GK, McAleer AF, Cox JD. Increased Survival Compared to Daily Radiation Therapy (QD-RT) for Limited Small Cell Lung Cancer Patients Treated with Concurrent Chemotherapy. A Supplement to Oncology 90(Suppl 3):S60, 3/2009.
54. Cox JD, Lee AK, Woo SY, Chang JY, Wei X, Komaki R, Gillin M. Proton Therapy and the Possibility of Clinical Trails. A Supplement to Oncology 90(Supl 3):S19, 3/2009.
55. Komaki R, Sejpal SV, Wei X, Allen PK, Amos R, Mohan R, Chang JY, Liao Z, Dong L, Cox JD. Significant Reduction of Bone Marrow Toxicity (BMT) for Patients with Locally Advanced (LA) NSCLC Treated with Confurrent Chemotherapy (CT) and Proton Beam Theerapy (PBT) Compared to Intensity Modulated Radiation Therapy (IMRT). A Supplement to Oncology 90(Suppl 3):S61, 3/2009.
56. Liao Z, Yuan X, Milas L, Liu Z, Wang LE, Tucker SL, MAo L, Wang XS, Martel M, Komaki R, Cox JD, Wei Q. Single nucleotide polymorphism of the TGF-B1 gene predicts risks of severe treatment related pneumonitis and distant metastasis in patients with non-small cell lung cancer treated with definitive radiotherapy. A Supplement to Oncology 90(Suppl 3):S87-88, 3/2009.
57. Komaki RU, Paulus R, Ettinger D. Videtic G, Bradley J, Glisson B, Choy H. Patterns of first failure in a phase II study of accelerated high dose thoracic radiation therapy (TRT) with concurrent chemotherapy for limited small-cell lung cancer (LSCLC): radiation therapy oncology group (RTOG) 0239. Proceedings of the 51st Annual ASTRO Meeting 75(3):S34, 2009.
58. Komaki R. Significant Reduction of Bone Marrow Toxicity (BMT) for Patients with Locally Advanced (LA) NSCLC Treated with Concurrent Chemotherapy (CT) and Proton Beam Therapy (PBT) Compared to Intensity Modulated Radiation Therapy (IMRT). Proceedings of Chicago Multi disciplinary Symposium in Thoracic Oncology 3(11):S303-, 11/2008.
59. Bucci MK, Ezhil M, Vedam S, Choi B, Dong L, McAleer MF, Munsell M, Komkai R, Balter P. 4D CT-Derived PTV Spares Normal Lung Volume Compared to Free Breathing CT-Derived PTV for Both Early and Late Stage Non-Samll Cell Lung Cancer Patients. A Supplement to Oncology 22(Suppl 1):17, 2008.
60. McAleer Mf, Balter P, Bucci MK, Kuruvila S, Komaki R, Chang JY. Capsular Contracture of Subcutaneous Breast Implant Following Hypofractionated Stereotactic Radiotherapy for Early-Stage Lung Cancer: A Case Report. A Supplement of Oncology 22(Suppl 1):57, 2008.
61. Grosshans D, Palmer M, Spicer C, Erice R, Cox JD, Komaki R, Chang J. Improving Cardiac Dosimetry A Comparison of the Alernative Beam Arrangements for IMRT Planning in Patients with Carcinoma of the Distal Esophagus. A Supplement of Oncology 22(Suppl 1):7, 2008.
62. Kong F, West B, Bonner J, Choy H, Gaspar LE, Komaki R, Sun A, Morris D, Wang L, Sandler HM, Movsas B. Patterns of practice in radiation therapy for non-small cell lung cancer among members of American Society of Therapeutic Radiology and Oncology. Proceedings of ASCO 25:432S, 2008.
63. Yordy JS, Balter P, McAleer MF, Palla SL, Nogueras-Gonzalez GM, Dong L, Komaki R, Bucci K. Physician-Therapist Agreement in Thoracic Patient Set-up Using Image-Guided Radiation Therapy. A Supplement to Oncology 22(Suppl 1):56, 2008.
64. Sejpal S, Komaki R, Wei X, Amos R, Allen P, Liu H, Liao Z, Chang JY, Cox JD. Preliminary Evaluation of Treatment Related Pneumonitis (TRP) by Proton Beam Radiotherapy (PBT) Compared to Intensity-Modulated Related Radiation Therapy (IMRT) in Patients With Locally Advnaced NSCLC Treated with Concurrent Chemotherapy. A Supplement to Oncology 22(Suppl 1):15, 2008.
65. Zhang S, Komaki R, Fang B, Chang JY. Radiation-Resistant Esophageal Cancer Stem Cell. A Supplement to Oncology 22(Supp 1):5, 2008.
66. Komaki R, Sejpal SV, Wei X, Allen P, Chang JY, Liao Z, Mohan R, Dong L, Amos R, Cox JD. Reduction of Bone Marrow Suppression for Patients With Stage III NSCLC Treated by Proton and Chemotherapy Compared with IMRT and Chemotherapy. PTCOG 47 Abstract Book:14, 2008.
67. Liao Z, Cox JD, Liu HH, Tucker SL, Komaki R, Mohan R, Martel M, Wei X, Allen PK. The Impact of Technological Advancement of Outcome for Patients with Unresectable locally advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Concomitant Chemoradiotherapy. A Supplement to Oncology 22(Suppl 1):15, 2008.
68. Chang JY, Balter P, Dong L, Liao Z, Bucci KM, Jeter M, McAleer ,Yang Q, Cox JD, Komaki R. 4D CT Based and Daily In-Room CT-guided Stereotactic Body Radiotherapy (SBRT) in Lung Cancer. Proceedings of ASTRO 69:88S, 2007.
69. Swisher S, Winters K, Komaki R, Ajani J, T. Wu T, W. Hofstetter W, A. Konski,. Willett.C. A Phase II Study of a Paclitaxel Based Chemoradiation Regimen with Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporting of RTOG 0246. Proceeding of ASTRO 69:106S, 2007.
70. Blumenschein Jr G, Moughan J, Curran W, Robert F, Fossella F, Werner-Wasik M, Doescher P, Choy H, Komaki R. A phase II study of cetuximab (C225) in combination with cheomradiation (CRT) in patients (pts) with stage III A/B non-small cell lung cancer (NSCLC): An interim report of the RTOG 0324 trial. Proceedings of ASCO 25:392S, 2007.
71. Lu C, Lee JJ, Komaki R, Herbst RS, Evan WK, Choy H, Desjardins P, Esparaz BT, Truong M, Fisch MJ. A phase III study of /E-941 with induction cheomtherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC) (NCI T99-0046, RTOG 02-07, MDA 99-303. Proceedings of ASCO 25:391S, 2007.
72. Liao Z, Cox JD, Liu H, Komaki R,Tucker SL, Mohan R, Martel M, Allen PK, Thames HD. Assessing The Impact Of Technological Advancement On Outcome For Patients With Unresectable Locally Advanced Non-small-cell Lung Cancer (nsclc) Receiving Concomitant Chemoradiotherapy. Proceedings of ASTRO 69:160S, 2007.
73. Wei X,. Komaki R, Allen PK, Garza VP, Liao Z, Chang JY, Guerrero TM, Bilton S, Cox JD. Effects of amifostine on acute and late toxicity of once daily and twice daily radiotherapy and concurrent chemotherapy for local advanced non-small lung cancer. Proceedings of ASTRO 69:476S, 2007.
74. McGovern SL, Liao Z, Bucci K, McAleer MF, Jeter MD, Chang JY, Huang EH, Cox JD, Allen PK, Komaki R. Gender Differences in NSCLC Outcomes. Proceedings of ASTRO 69:160S, 2007.
75. Konski A, Bhargavan M, Owen J, Komaki R, Langer C, Byhardt R, Paulus R, H. Choy, Bruner D, Curran Jr W. Less is not Always More”: An Economic Analysis of Radiation Therapy Oncology Group 94-10. Proceedings of ASTRO 69:182S, 2007.
76. Jin, HK, Liao, ZX, Tucker, SL, Liu, HH, Wei, X, Mohan, R, Cox, JD, Komaki, R. Non-smokers and former smokers at increased risk for TRP in Chemoradiation for NSCLC. Proceedings of ASTRO 69:59S, 2007.
77. Sun A, Wang L, Choy H, Gaspar L E., Komaki R, Bonner JA, Sandler HM, Movsas B, Kong FM. Radiation Oncologists from Canada and the United States have significantly different patterns of practice for patients with Non-Small Cell Lung Cancer. Proceedings of ASTRO 69:57S, 2007.
78. Torres MA, Guerrero T, Castillo R, Cody D, Komaki R, Travis EL. Raduction of pulmonary compliance in mice following thoracic radiation. Proceedings of the American Radium Society Suppl 3:47S, 2007.
79. Movsas B, Moughan J, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Byhardt R. Randomized trail of amifostine in locally advanced non-small cell lung cancer (NSCLC) patients receiving chemotherapy and hyperfractionated radiation (HRT): long-term survival results of Radiation Therapy Oncology Group (RTOG). Proceedings of ASCO 25:391S, 2007.
80. Komaki R, Moughan J, Ang K, Curran W, Robert F, Thariat J, Zhang H, Werner-Wasik M, Choy H, Blumenschein G. RTOG 0324: A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): Correlation between EGFR expression and the patients outcome. Proceedings of ASTRO 69:57S, 2007.
81. Furutani K, Komaki R, Imagumbai T, Jacoby JJ, Massarelli E, Korshunova MK, Ryan A, Jurgensmeier JM, Herbst RS, O'Reilly MS. Targeted therapy against VEGFR-1, -2, and -3 by AZD2171 blocks tumor growth and angiogenesis, and enhances paclitaxel efficacy in an orthotopic lung cancer model. Proc for AACR, 2007.
82. Komaki R, Moughan J, Ettinger D, Videtic G, Bradley J, Glisson B, Choy H. Toxicities in a phase II study of accelerated high dose thoracic radiation therapy (TRT) with concurrent cheomtherapy for limited small cell lung cancer (LSCLC) (RTOG 0239). Proceedings of ASCO 25:438S, 2007.
83. Komaki, Ritsuko R. A Randomized Phase II Study of two paclitaxel based chemoradiotherapy for patients with the non-operative esophageal cancer. ASTRO, 11/2006.
84. Huang HH, Liao Z, Cox JD, Wei X, Komaki R. Comparison of outcomes for locally advanced inoperable non-small cell lung cancer treated using concurrent chemoradiation with vs. without induction chemotherapy. Proc American Radium Society 20 - Suppl 3:20, 4/2006.
85. Komaki, Ritsuko R. Comparison of outcomes for patients with medically inoperable stage I non-small cell lung cancer treated with two-dimensional vs. three dimensional radiotherapy. Proc American Radium Society 20 - Suppl 3:20, 4/2006.
86. Yaremko B, Guerrero T, Harvey M, Komaki R. Pulmonary function imaging from four-dimensional computed tomography for radiation oncology. Proc American Radium Society 20 - suppl 3:24, 4/2006.
87. Torres MA, Guerrero T, Castillo R, Cody D, Komaki R, Travis EL. Reduction of pulmonary compliance in mice following thoracic radiation. Proc American Radium Society 20 - suppl 3:47, 4/2006.
88. Komaki R. A Randomized Phase II Study of two paclitaxel based chemoradiotherapy for patients with the non-operative esophageal cancer. Proceedings of ASTRO 66:327, 2006.
89. Huang HH, Liao Z, Cox JD, Wei X, Komaki R. Comparison of outcomes for locally advanced inoperable non-small cell lung cancer treated using concurrent chemoradiation with vs. without induction chemotherapy. Proceedings American Radium Society Suppl 3:20S, 2006.
90. Komaki R. Comparison of outcomes for patients with medically inoperable stage I non-small cell lung cancer treated with two-dimensional vs. three dimensional radiotherapy. Proceedings American Radium Society Suppl 3:20S, 2006.
91. Curran W, Scott C, Langer C, Komaki R, Lee J, Hauser S, Movsas B, Wasserman T, Sause W, Cox J. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 94-10. J Clin Oncol 22:621 (#2499), 2006.
92. Yaremko B, Guerrero T, Harvey M, Komaki R. Pulmonary function imaging from four-dimensional computed tomography for radiation oncology. Proceedings American Radium Society Suppl 3:24S, 2006.
93. Liao Z, Komaki R, Milas L, Chen Y, Kies M, Chang J, Jeter M, Guerrero T, Blumenschein G, Cox J. A dose escalation clinical trial using thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer (NSCLC). Proc of IASLC. Lung Cancer 49(Suppl 2):S372 (#P-959), 2005.
94. Werner-Wasik M, Swann S, Curran W, Robert F, Komaki R, Lee CP, Jafar S, Share R, Choy H, Blumenschein G. A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 trial. Proc ASCO 23:654s (#7135), 2005.
95. Blumenschein G, Swann S, Curran W, Robert F, Werner-Wasik M, Lee C, Jafar S, Shara R, Choy H, Komaki R. A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 trial. Proc of IASLC. Lung Cancer 49(Suppl 2):S78 (#PD-039), 2005.
96. Lu C, Komaki R, Herbst RS, Evans WK, Lee JJ, Truong M, Moore CA, Choy H, Bleyer A, Fisch MJ. A phase III study of AE-941 with induction chemotherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC) (NCI T99-0046, RTOG 02-70, MDA 99-303): An interim report of toxicity and response. Proc ASCO 23:656s (#7144), 2005.
97. Yom S, Liao Z, Liu H, Allen P, Chang J, Jeter M, Guerrero T, Stevens C, Cox J, Komaki R. Analysis of acute toxicity results of intensity modulated (IMRT) in the treatment of non-small cell lung cancer (NSCLC). Proc of IASLC. Lung Cancer 49(Suppl 2):S52 (#O-152), 2005.
98. Fang CL, Komaki R, Allen P, Guerrero T, Mohan R, Cox J. Comparison of outcomes for patients with medically inoperable stage I non-small cell lung cancer treated with two-dimensional versus three-dimensional radiotherapy. Proc of IASLC. Lung Cancer 49(Suppl 2):S49 (#O-142), 2005.
99. Komaki R, Swann S, Byhardt R, Cox J, Scot C, Sause W. Does response rate in the induction chemotherapy predict survival for locally advanced non-small cell lung cancer (LANSCLC)? Secondary analysis of RTOG 8804/8808. Proc of IASLC. Lung Cancer 49(Suppl 2):S88 (#PD-074), 2005.
100. Komaki R, Allen P, Glisson B, Lu C, Fossella F, Liao Z, Jeter M, Stevens C, Chang J, Guerrero G, Blumenschein G. Hyperfractionated/accelerated thoracic radiation therapy (HFXRT) increased survival compared to daily RT (QDRT) for limited small cell lung cancer (LSCLC) with concurrent chemotherapy (ChT). Proc ASCO 23:659s (#7158), 2005.
101. Chang J, Dong L, Mohan R, Liao Z, Cox J, Komaki R. Image-guided proton radiotherapy for medically inoperable stage I non-small cell lung cancer. Proc of IASLC. Lung Cancer 49(Suppl 2):S93 (#PD-088), 2005.
102. Swann RS, Machtay M, Komaki R, Sause WT, Langer CJ, Byhardt RW, Curran WJ. Impact of overall treatment time during concurrent chemoradiotherapy for locally advanced NSCLC: An RTOG secondary analysis. Proc ASCO 23:635s (#7061), 2005.
103. Basir S, Fossella F, Hwang L, Lu C, Komaki R, Zinner R. Loco-regional progression after induction chemotherapy may predict the development of M1 disease after the initiation of concurrent chemo-radiation in stage III NSCLC. Proc of IASLC. Lung Cancer 49(Suppl 2):S77 (#PD-036), 2005.
104. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter W, Liao Z, Komaki R, Rashid A, Hamilton SR, Wu T-T. Number of lymph nodes with metastasis predict survival in patients with esophageal or esophagogastric junction adenocarcinoma treated with preoperative chemoradiation. Proc ASCO 23:319s (#4046), 2005.
105. Komaki R, Allen P, Roth J, Swisher S, Rice D, Fossella F, Herbst R, Oh Y, Munden R, Cox J. Optimal treatment for superior sulcus tumors (SST): Surgery first followed by adjunct RT/ChT improved survival for patients with resectable SST. Proc of IASLC. Lung Cancer 49;Suppl 2:S79 (#PD-044), 2005.
106. Machtay M, Swann S, Komaki R, Sause W, Langer C, Byhardt R, Curran W. Overall treatment time during concurrent chemoradiotherapy and outcomes: An RTOG secondary analysis. Proc of IASLC. Lung Cancer 49(Suppl 2):S17 (#O-042), 2005.
107. Guerrero T, Sanders K, Castillo R, Ribera B, Cody D, Price RBidaut L, Komaki R. Pulmonary compliance imaging in rodents. Proc BioMech, 2005.
108. Machtay M, Swann S, Komaki R, Byhardt R, Paulus R, Sause W, Curran W, Albain K, Movsas B. What is the meaning of local-regional control after chemoradiation for locally advanced NSCLC? An RTOG analysis . Proc of IASLC. Lung Cancer 49(Suppl 2):S17 (#O-041), 2005.
109. Komaki R. Cytoprotection and target volume definition based on PET/CT. The 4th Takahashi Memorial International Workshop on 3 Dimensional Conformal Radiotherapy, Nagoya Japan, 98-99, 2004.
110. Komaki R, Allen PGlisson B, Milas L, Charles L, Kaplan B, Fossella F, Liao Z, Jeter M, Stevens C, Chang J, Guerrero T. Hyperfractionated and accelerated thoracic radiation therapy (HFXATRT) increased survival compared to daily TRT (QDTRT) for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy. Proc ASTRO 60:S203 (#123), 2004.
111. Swisher SG, Ajani JA, Chirieac L, Vaporciyan AA, Wu TT, Hunt KK, Correa AM, Komaki R, Rice DC, Walsh GL, Roth JA. Impract of pathologic response on pTNM esophageal cancer staging system following preoperative chemoradiation (CRT). Proceedings of 116th Meeting of the Southern Surgical Association, Palm Beach FL, 55-5, 2004.
112. Liao Z, Chen Y, Komaki R, Cox JD, Milas L. A phase I study combining thoracic radiation (RT) with celecoxib in patients with non-small cell lung cancer (NSCLC). Proceedings ASCO 22:216 (#867), 2003.
113. Lu C, Komaki R, Herbst RS, Evans WK, Smith TL, Moore CA, Kilbye SL, Choi NC, Choy H, Bleyer A. A phase III study of AE-941 (Neovastat) with induction chemotherapy (IC) and concomitant chemoradiotehrapy (CRT) for stage III non-small cell lung cancer (NSCLC) (NCI T99-0046, RTOG 02-70, MDA 99-303): An interim analysis of toxicity and response. Lung Cancer 42(Suppl 2):S90, 2003.
114. Bradley JD, Graham MV, Winter KW, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B. Acute and late toxicity results of RTOG 9311:A dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 57:S137 (#23), 2003.
115. Werner-Wasik M, Scott C, Movsas B, Langer C, Sarna L, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Byhardt R. Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT): Results of the Radiation Therapy Oncology Group (RTOG) 98-01 study. Int J Radiat Oncol Biol Phys 57:S216 (#152), 2003.
116. Forster KM, Stevens CW, Kitamura K, Chang JY, Cox JD, Guerrero TM, Jeter M, Liao Z, Starkschall G, Komaki R. Changes of tumor motion patterns during a course of radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 57:S234 (#181), 2003.
117. Machtay M, Swann RS, Komaki R, Langer C, Byhardt RW, Sause WT, Curran WJ. Cisplatin dose delivery and survival in concurrent chemoradiation for stage III NSLC: An RTOG secondary analysis. Lung Cancer 42(Suppl 2):S77, 2003.
118. Swisher S, Ajani JA, Komaki R, Putnam J, Walsh G, Liao Z, Yao J, Faust J, Wu T-T, Roth J. CPT-11-taxotere-5-FU regimen for induction and concurretn chemoradiotherapy prior to surgery in patients with resectable esophageal or GEJ carcinoma. Proceedings ASCO 22:272 (#2093), 2003.
119. Itasaka S, Komaki R, Herbst RS, Hunter NR, Onn A, Bucana CD, Milas L, Ang KK, O’reilly MS. Endostatin blocks endothelial repopulation after radiation therapy. Proceedings of the AACR 44 (#115), 2003.
120. Komaki R. Hyperfractionated and accelerated thoracic radiation therapy (HFXA/TRT) incrased survival compared to daily TRT for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy(ChT). Cancer J 9:489 (#18), 2003.
121. Komaki R, Glisson B, Allen P, Fossella F, Liao Z, Stevens C, Blumenschein G, Hong WK, Herbst R, Pisters K. Hyperfractionated and accelerated thoracic radiation therapy (HFXA/TRT) increased survival compared to daily TRT for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy. Lung Cancer 42; Suppl 2:S24, 2003.
122. Langer C, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson J. Patterns of care survey (PCS) in locally advaned non-small cell lung cancer (LA-NSCLC) and limited small cell lung cancer (LD-SCLC): How well does current practice follow the literature. Int J Radiat Oncol Biol Phys, 2003.
123. Komaki R, Swann S, Ettinger D, Glisson B, Sandler A, Movsas B, Byhardt R. Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation Therapy Oncology Group (RTOG) protocol 9712. Lung Cancer 42(Suppl 2):S104, 2003.
124. Komaki R, Swann S, Ettinger D, Glisson B, Sandler A, Movasa B, Byhardt R. Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation Therapy Oncology Group RTOG 9712. Int J Radiat Oncol Biol Phys 57:S139 (#25), 2003.
125. Komaki R, Swann S, Ettinger D, Glisson B, Sandler A, Movsas B, Byhardt R. Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patietns with limited small cell lung cancer (LSCLC). Radiation Therapy Oncology Group (RTOG) protocol 97-12. J Clin Oncol 22:631 (#2539), 2003.
126. Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Axelrod R, Byhardt R. Phase III study of amifostine in patients with locally advanced non-small cell lung cancer (NSCLC) receiving chemotehrapy & hyperfractionated radiation (CHEMO/HFXRT): Radiation Therapy Oncology Group (RTOG) 98-01. J Clin Oncol 22:636 (#2559), 2003.
127. Wakelee HA, Stephenson P, Keller SM, Wagner H, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIa non-small cell lung cancer (NSCLC) leads to higher than expected risk of death from intercurrent disease. J Clin Oncol 22:633 (#2545), 2003.
128. Movsas B, Moughan J, Komaki R, Chou H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, Owen J. Radiotherapy patterns of care study in lung carcinoma. Lung Cancer 42(Suppl 2):S30, 2003.
129. Komaki R. Reducing toxicity of combined therapies (Plenary Lecture PL5.2). Proc 17th Asia Pacific Cancer Conference (APCC), Kuta Bali, Indonesia:29, 2003.
130. Graham MV, Paulus R, Ettinger DS, Bradley J, Pilepich M, Machtay M, Komaki R, Atkins J, Curran WJ, Scott C. RTOG 9705, A phase II atrial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIA non-small cell lung cancer (NSCLC) patients – promising long term survival results. Int J Radiat Oncol Biol Phys 57:S140 (#28), 2003.
131. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Roth J, Putnam JB, Moran C, Cox JD. SUV by FDG-PET predicts outcome of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 57:S166 (#71), 2003.

Book Chapters

1. Komaki R, Tsao A, Mehran R. Lung cancer. In: Monogram: Houston, Texas. In Press.
2. Komaki R, Tsao A, Mehran R. Non-small cell lung cancer. In: 60 Years of Survival Outcomes at The University of Texas MD Anderson Caner Center. Ed(s) Rodriguez MA, Walters RS, Burke TW. Springer Science + Business Media New York: New York, 45-63, 2013.
3. Erasmus JJ, Stewart DJ, Komaki R, Swisher SG. Lung Cancer. In: Oncologic Imaging: A multidisciplinary approach. Elsevier Saunders: Philadelphia, PA, 35-61, 2012.
4. Blumenschein GR, Paulus R, Curran WJ, Robert F, Fossella F, Wasik MW, Herbst RS, Doescher PO, Choy H, Komaki R. A Phase II study of cetuximab (C225) in combination with chemoradiation in patients with stage IIIa/b non-small cell lung cancer (NSCLS): Radiation Therapy Oncology Group Study RTOG0324. In: J Clin Oncology, e-Book.
5. Bedford JS, Dinger KH, Howell RW, Komaki R, Shaw RP. In: NCRP Report No. 167. 167. National Council on radiation Protection and Measurement: Bethesda, MD, 2011.
6. Jeter M, Komaki R, Cox JD. Radiation time, dose, and fractionation in the treatment of lung cancer. In: Advances in Radiation Oncology in Lung Cancer, 2. Ed(s) Jeremic B. Springer-Verlag: Berlin Heidelberg, 129-141, 2011.
7. Komaki R, Chang JY, Liao Z, Cox JD, Mason, KA, Milas L. Radioprotectors and chemoprotectors in the management of lung cancer. In: Advances in radiation Oncology in Lung Cancer, 2. Ed(s) Jeremic B. Springer-Verlag: Berlin Heidelberg, 223-245, 2011.
8. Iyengar P, Chan S, Komaki R. Targeting tumors and personalizing individual treatments for radiation therapy. In: Targetd therapy for solid tumors and hematologic malignancies. Nova Science: New York, 295-310, 2011.
9. Hristov B, Lin S, Christodouleas J. Small cell lung cancer. In: Radiation Oncology: A Question-Based Review. Lippincott Williams & Wilkins: Philadelphia, 2010.
10. Liao Z, Komaki R, Cox J. The esophagus. In: Radiation Oncology, Ninth. Mosby: Philadelphia, PA, 461-92, 2010.
11. Komaki R, Travis E, Cox JD. The lung, pleura, and thymus. In: Radiation Oncology - Ninth Edition. Mosby: Philadelphia, PA, 424-58, 2010.
12. Komaki R, Cox JD. Radiation therapy for carcinoma of the lung cancer. In: General Thoracic Surgery. 2, 7. Ed(s) Shields TW, LoCicero J, Reed C, Feins R. Lippincott Williams and Wilkins: Philadelphia, PA, 1457-1495, 2009.
13. Ang K, Cox JD. Thorax. In: Radiation Oncology - 9th Edition, 2009.
14. Liao Z, Fossella F, Komaki R. Combinations of radiation therapy and chemotherapy for nonsmall cell lung carcinoma. In: Lung Caner, 3rd Edition. Blackwell: Malden MA, 283-314, 2008.
15. Chang JY, Bradley J, Govindan R, Komaki R. Lung. In: Principles and Practice of Radiation Oncology. Lippincott Williams & Wilkins: Philadelphia, 2007.
16. Onn A, Vaporciyan A, Chang JY, Komaki R, Roth JA, Herbst RS. Cancer of the lung. In: Cancer Medicine 7, 1179-1224, 2006.
17. Swisher SG, Komaki R, Lynch PM, Agani JA. Esophageal carcinoma. In: Gastrointestinal Cancer, M. D. Anderson Cancer Care Series. Springer-Verlag: New YOrk, 232-245, 2005.
18. Komaki R, Liu H, Murshed H. Lung Cancer. In: Practical Essentials of Intensity Modulated Radiation Therapy. Lippincott Williams & Wilkins, 255-274, 2005.
19. Komaki R Cox JD. Radiation Therapy for Carcinoma of the Lung. In: General Thoracic Surgery. Lippincott Williams & Wilkins, 1377-1388, 2005.
20. Travis E Komaki R. Treatment-related lung damage. In: Lung Cancer Principles and Practice. Lippincott Williams & Wilkins, 545-567, 2005.
21. Swisher SG, Komaki R, Lynch PM, Ajani JA. Esophageal carcinoma. In: Anderson Associates Monograph on Gastroinstestinal Cancer 2004. Springer Verlag, 268-280, 2004.
22. Komaki R, Chang J, Liao Z, Cox JD, Mason KA, Milas L. Radioprotectors and chemoprotectors in the management of lung cancer. In: Medical Radiology-Advances in Radiation Oncology in Lung Cancer. Springer-Verlag, 2004.
23. Komaki R Chang E. Whole-brain Radiation Therapy. In: Intracranial Metastases. Blackwell Publishing, 126-138, 2004.
24. Bradley J, Govindan R, Komaki R. Lung. In: Principles and Practice of Radiation Oncology. Lippincott Williams & Wilkins, 1201-1243, 2003.
25. Komaki R Cox JD. The esophagus. In: Radiation Oncology. Mosby, 429-443, 2003.
26. Komaki R, Travis EL, Cox JD. The lung and thymus. In: Radiation Oncology. Mosby, 399-426, 2003.

Books (edited and written)

1. Cox JD, Chang JY, Komaki R. Ed(s) Cox JD, Chang JY, Komaki R. Image-Guided Radiotherapy of Lung Cancer. Informa, 2007.
2. Fossella FV, Komaki R, Putnam JB. Implementation of multidisciplinary care in the treatment of patients with lung cancer. In: Lung Cancer - Japanese Edition. Springer: Germany, 2003.

Last updated: 4/16/2014